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ABSTRACT 
 
Kristin M. Healey: Latent profile analysis and conversion to psychosis:  
Characterizing subgroups to enhance risk prediction 
(Under the direction of David L. Penn) 
 
Background: Groups at clinical high risk (CHR) of developing psychosis are 
heterogeneous, composed of individuals presenting with several different clusters of diagnostic 
symptoms (e.g., affective symptoms, anxiety symptoms, subpsychotic symptoms). It is likely 
that there are subgroups within those at CHR, each associated with different constellations of 
symptoms and associated probabilities of conversion.  
Method: Latent Profile Analysis (LPA) has shown promise in identifying subgroups with 
clinically useful profiles of risk indicators among CHR individuals.  The current study used a 
LPA model to ascertain subgroups in a combined sample of CHR (n = 171) and help-seeking 
controls (HSC; n = 100). Indicators in the LPA model included baseline Scale of Prodromal 
Symptoms (SOPS), total depressive symptoms (CDSS), and neurocognitive performance. 
Subgroups were further characterized using covariates measuring demographic and clinical 
features. General linear mixed models for repeated measures were used to examine within group 
change over time and longitudinal subgroup comparisons on a measure of social functioning. 
Results: LPA resulted in three classes: class 1 (mild) had the lowest transition risk 
(5.6%), the lowest scores across SOPS symptoms and depression scores, and intact 
neurocognitive performance; class 2 (positive-depressive) had a transition risk of 14.2%, the 
highest positive symptoms, mild or lesser negative symptoms, and moderate depression; class 3 
(negative-neurocognitive) had the highest transition risk (29.3%), the highest negative 
  iv 
symptoms, neurocognitive impairment, and social cognitive impairment. Classes 2 and 3 
evidenced similarly poor social functioning. 
Conclusions: Results support a subgroup approach to the research, assessment, and 
treatment of help seeking individuals. Three classes emerged with good separation on a majority 
of indicator variables, including a class that may be an early manifestation of the deficit subtype. 
Development of efficacious treatments for early neurocognitive deficits and negative symptoms 
are indicated. Results underline the profound social dysfunction across help seeking individuals 
and need for improved treatments. 
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Introduction 
 
The present study investigated a novel latent profile analysis (LPA) methodology to 
better understand latent subgroups among a heterogeneous group of individuals at clinical high 
risk (CHR) of developing psychosis. Subgroups have the potential to enhance specificity in 
predicting who among CHR individuals is at risk of transitioning to a frank psychotic disorder. 
Early detection and intervention in emerging psychosis is critical to the aim of reducing societal 
burden associated with psychotic spectrum illnesses. The development of schizophrenia and 
other psychotic disorders is often associated with significant impairment in individuals 
diagnosed with schizophrenia, the cost of which amounts to an estimated $30 billion per year and 
is likely as a result of decline in social and role functioning (Wu et al., 2002). Early intervention 
may aid in both prevention of frank psychosis and amelioration of dysfunction that precedes the 
onset of psychosis. To this end, it is crucial to develop both sensitive and specific criteria that 
enable early identification that generalizes to clinical settings. While current at-risk criteria are 
the most reliable predictors of psychosis at present, research thus far indicates that such models 
need improvement (for a review, see Fusar-Poli, Borgwardt, et al., 2013). 
A recent meta-analysis indicated that a fraction of prospectively identified individuals 
have a true vulnerability to developing schizophrenia, as 36% of CHR individuals transitioned to 
psychosis after three years (e.g., Fusar-Poli, Bonoldi, et al. 2012). To date, studies investigating 
predictors of conversion to psychosis and variables associated with functional decline have relied 
upon logistic regression models (e.g., Klosterkötter, Schultze-Lutter, Bechdolf, & Ruhrmann, 
2011; Rurhmann et al., 2010; Seidman et al., 2010). Regression models assume that the risk of 
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developing a psychotic disorder is evenly distributed throughout CHR individuals (Hagenaars & 
McCutcheon, 2002). However, CHR groups are psychopathologically heterogeneous, composed 
of individuals presenting with several different clusters of diagnostic symptoms (e.g., affective 
symptoms, anxiety symptoms, subpsychotic symptoms) (e.g., Fusar-Poli, Bechdolf, et al., 2013; 
Salokangas et al., 2012; Wigman et al., 2012). It is likely that there are subgroups within the 
heterogeneous CHR group, each associated with different constellations of symptoms and 
associated probabilities of conversion. LPA models may ascertain such subgroups and provide a 
more accurate model of who is truly at risk of developing schizophrenia, resulting in a clinically 
useful profile of risk indicators.  
The introduction will provide an overview of the most relevant background concerning 
definition and assessment of the prodromal state, rationale for the utility of subgroup analyses in 
CHR, characteristics associated with conversion to psychosis, as well as other features associated 
with the CHR state. More specifically, the introduction begins with a definition of the prodromal 
state, as well as an overview of common methods used to assess risk for psychosis. This will lead 
to a brief review of research supporting the heterogeneity of CHR subgroups and resulting utility 
of the latent profile approach. Following this review, there will be a synthesis of studies that have 
examined clinical, functional, and neurocognitive indices that may predict transition from CHR 
to a frank psychotic disorder. This will lead to a discussion of covariates potentially associated 
with the CHR state, such as social cognition, internalized stigma, substance use, racial and ethnic 
minority status, and premorbid functioning. Functional trajectory in CHR individuals and 
determinants of functioning will then be reviewed. The introduction will end with elaboration of 
the present study, aims, and hypotheses. 
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The Prodromal State 
 
Definition and Assessment of the Prodromal State 
Central to the task of early detection and intervention is accurate identification of who 
has entered the prodromal stage of illness and is at risk of developing a psychotic disorder. At 
present, the field has identified both a later prodromal phase (CHR) and an earlier prodromal 
phase. The early prodrome predates the CHR stage, and is characterized by distinct subthreshold 
symptoms (i.e., basic symptoms) that will be discussed below. This section will briefly 
summarize definitions of the prodromal state and associated psychotic risk assessments to gain a 
foundation for understanding the present prediction model and associated indices.  
The prodrome is broadly defined as a set of changes from a person’s premorbid mental 
and functional state characterized by sub-threshold psychotic symptoms in the period of time 
preceding onset of psychosis. While the prodrome was first described in 1932 (Mayer-Gross, 
1932), it was not until the late 1980’s that research groups empirically investigated early signs of 
psychosis (Huber & Gross, 1989; Riecher et al., 1989). In the first prospective longitudinal study 
of risk, it was found that 73% of patients reported experiencing subthreshold symptoms 
consistent with the prodromal phase, which lasted an average of 5 years (Häfner et al., 1992; 
Häfner et al., 1998). As a result, several research groups developed and validated operational 
criteria and assessments to reliably detect individuals at an increased risk of developing 
psychosis, most commonly referred to in the literature as an “at-risk mental state” (ARMS), 
“ultra-high risk” (UHR) state, and “Clinical High Risk” (CHR) state. For parsimony, the 
subsequent text will refer to this later prodromal risk state as CHR. 
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Yung and McGorry (1996a; 1996b) were the first to establish psychometrically validated 
psychosis risk criteria. The first tool to assess prodromal states was the Comprehensive 
Assessment of At-Risk Mental States (CAARMS), a prospective interview and rating system 
(Yung & McGorry, 1996a; Yung & McGorry, 1996b). In the CAARMS, individuals are assessed 
on 27 symptoms across seven core dimensions, including negative symptoms (e.g., avolition), 
positive symptoms (e.g., perceptual abnormalities), and general symptoms (e.g., impaired 
tolerance to normal stress). Symptom ratings are used to determine risk status, which can be 
further delineated into three main subtypes of prodromal syndrome: attenuated positive 
symptoms (APS), genetic risk and familial risk for psychotic illness with recent decline in 
functioning (GRD), and brief intermittent psychotic states (BLIPS) (Yung & McGorry, 1996a; 
Yung & McGorry, 1996b). Early validation studies of CAARMS criteria evidenced enhanced 
detection rates of individuals at risk of developing a psychotic disorder, with an incidence of 
psychosis in the CHR group of 30-50% over two years. This provided support for the idea that 
prodromal individuals are both identifiable and at imminent risk of developing psychosis 
(Schaffner & McGorry, 2001).  
The establishment of formal risk criteria has allowed for continued investigation of the 
predictive validity of these criteria, which has answered the question of how many individuals 
“convert” from a CHR state to a full-blown psychotic disorder (Yung & McGorry, 1996a; Yung 
& McGorry, 1996b). In the high-risk literature, “conversion” has been defined using varying 
criteria. Criteria tend to be in accordance with those established by Yung and colleagues (1998) 
as at least one sub-threshold positive symptom reaching a fully psychotic level multiple times per 
week, for longer than one week. For example, commonly accepted criteria stipulate that the 
symptom must occur multiple times per week for at least one month, or at least one day if the 
  5 
symptom is significantly dysfunctional or dangerous (Miller et al., 2003). As such, individuals 
that progress from a psychometrically determined risk state to a major psychotic diagnosis will 
be referred to as “converters,” and those that do not will be referred to as “nonconverters.”  
Researchers have also explored prodromal symptoms that emerge prior to CHR, and 
referred to such symptoms as “basic symptoms” (BS; Klosterkötter, Ebel, Schultze-Lutter, & 
Steinmeyer, 1996). BS are comprised of subtler alterations from a person’s premorbid state, 
which can include subjective alterations of perception, language, attention, body perception, and 
thought processing. BS symptoms cluster into two partially overlapping subgroups of items: 
cognitive-perceptive (COPER) and cognitive (COGDIS) symptoms (Schultze-Lutter, 
Klosterkötter, Picker, Steinmeyer, & Ruhrmann, 2007). The COGDIS cluster is the most 
predictive of subsequent psychosis (Schultze-Lutter et al., 2007). BS appear similar to CHR 
symptoms conceptually, but are distinct in their independence from content related to reality 
orientation, abnormal thought content, and insight into symptoms’ pathological nature.  Rather, 
BS and CHR symptoms and criteria are considered complementary sets of clinical symptoms, 
thus both tend to be used when assessing the prodromal state to best predict later conversion 
(Fusar-Poli, Borgwardt, et al., 2013). 
While CHR individuals are at increased risk of developing a psychotic disorder, the vast 
majority of prospectively identified individuals do not convert (Fusar-Poli, Bonoldi et al., 2012). 
Such a high proportion of false-positives undermine the utility of the CHR status, and calls for 
enhanced understanding of the CHR state and specificity in predicting conversion.  
Potential Subgroups in CHR Populations 
Recently, researchers have called for the reconceptualization of the CHR state as a group 
broadly at risk of developing various forms of psychopathology rather than at specific risk for 
  6 
schizophrenia (Fusar-Poli, Yung, McGorry, & van Os, 2014). A recent meta-analytic review 
found that 73% of presenting CHR individuals meet criteria for a comorbid axis I disorder in 
addition to CHR criteria (Fusar-Poli, Nelson, Valmaggia, Yung, & McGuire, 2014). Individuals 
at CHR often present with a mixture of psychopathologies in addition to subthreshold psychotic 
symptoms, such as anxious/mood disorders, personality disorders, and substance use disorders 
(Salokangas et al., 2012; Wigman et al., 2012; Woods et al., 2009; Yung et al., 2008). CHR 
groups are characterized by high distress resulting in help-seeking behaviors, though this distress 
is likely associated with heterogeneous symptom profiles. Heterogeneity impedes research by 
obscuring potentially discrete subtypes, which then hinders clinical research, evaluation, and 
treatment. A recent expert consensus paper confirmed that due to the dearth of support for 
diagnostic reliability and validity, the Attenuated Psychotic Syndrome was not included in the 
recent Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5; APA) 
(Yung et al., 2012). While it remains unknown what disorders CHR individuals may develop, 
accurate risk criteria are needed to ensure that treatment can be appropriately tailored to the 
emerging diagnosis.   
Thus far, psychosis risk assessment research has primarily focused on identifying 
endophenotypes rather than transdiagnostic symptomatology. While endophenotypic research 
has identified several key features associated with the CHR state, results have had limited 
implications for effective treatment and amelioration of dysfunction thus far. Heterogeneity 
within the CHR population is acknowledged, but the only widely accepted subgroups are 
dictated by conceptual genetics (i.e., genetic risk and deterioration (GRD) and schizotypal 
personality disorder, which are presumed to have genetic components). Seeking subgroups to 
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investigate symptomatic heterogeneity in CHR groups may lead to better identification of who 
will subsequently convert to a psychotic disorder.  
Researchers have called for two different methods of parsing heterogeneity in CHR to 
create diagnostically meaningful subgroupings, risk stratification models and latent subgroup 
models. Risk stratification models are well established in medical disease models (e.g., cancer 
staging, heart disease risk). Such models use available predictive indices to generate a prognostic 
risk score for each CHR individual. Prognostic risk scores may be stratified into different risk 
classes, yielding a “prognostic index” with associated likelihood of transition to psychosis. Thus, 
this process produces specific, individualized hazard rates informing both degree of risk and time 
to transition (Ruhrmann, Schultze-Lutter, Schmidt, Kaiser, & Klosterkötter, 2014). Staging was 
first applied to mental illness risk models by Ruhrmann et al. (2010), which used regression to 
stratify the CHR group by prognostic index into four risk groups, indicating that a differentiated 
estimation of current risk may further enhance predictive accuracy. This approach has since been 
replicated with success in large prospective studies of CHR individuals incorporating additional 
predictor indices (Michel, Ruhrmann, Schimmelmann, Klosterkötter, & Schultze-Lutter, 2014; 
Nieman et al., 2013). However, risk stratification methods rely on logistic regression, which 
assumes that the risk of conversion is evenly distributed throughout the sample (Hagenaars & 
McCutcheon, 2002). Given the heterogeneity of CHR samples, this assumption may be 
erroneous, and alternate methodological approaches may be warranted.  
Latent subgroup models, such as LPA, aim to identify homogenous subgroups within 
heterogeneous cohorts. Use of such latent subgroups may permit more accurate assessment of 
true variance, and thus improve measurement of associations between CHR individuals and 
outcomes of interest (e.g., symptoms and functioning). Latent subgroups may emerge from the 
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broader CHR cohort, each with independent, specific symptom constellations with differential 
associations with later conversion and functional ability. Latent subgroup models may provide a 
possible path to improved accuracy in identifying who among the CHR group will subsequently 
convert to psychosis. Recent imaging studies have provided support for latent subgroups 
underlying CHR populations, finding significant neurobiological heterogeneity in gray matter 
volume within the CHR group (Modinos et al., 2014). Prior to such findings, the field of imaging 
posited that CHR individuals share similar neuroanatomical alterations. This work underlines 
heterogeneous psychopathologies’ influence on both psychopathological and neurobiological 
features, with implications for both psychological and psychotropic treatments. 
Latent Profile Methods in CHR 
Latent subgroup models are a relatively novel approach in explicating risk in CHR 
groups, and are within a group of statistical methods known as latent variable mixture modeling 
(Hagenaars & McCutcheon, 2002). LPA is a specific type of latent variable mixture modeling for 
use with continuous variable indicators. LPA is also referred to in the literature by other names, 
most commonly “latent class cluster analysis” (LCCA; Vermunt & Magidson, 2002). When 
categorical variables are used as indicators, the technique is referred to as latent class analysis 
(LCA), though LPA and LCA are often used interchangeably irrespective of indicator variable 
type. Latent variable mixture modeling has only been applied in three studies thus far in CHR 
groups, all of which utilize continuous indicator variables (Raballo et al., 2014; Valmaggia et al., 
2013; Velthorst et al., 2013). Two of these studies investigated direct associations between 
classes and subsequent conversion to psychosis (Valmaggia et al., 2013; Velthorst et al., 2013) 
while the other did not (Raballo et al., 2015).  
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Raballo et al. (2014) sought to identify schizophrenia proneness subtypes among a 
moderately large sample of CHR individuals (n = 81) and individuals with first episode 
psychosis (n = 86). LCA applied to the full sample’s 17-item schizophrenia checklist scores 
resulted in a 3-class model, with the class at the highest proneness of developing psychosis 
characterized by increased paranoid features (e.g., self-referential ideation, persecutory ideation) 
and increased disturbed subjective experiences (e.g., alterations in perceptual vividness and 
subclinical hallucinatory experiences). Of note, there was little differentiation between classes on 
symptoms relating to functionality or affective disturbances. However, this study was limited by 
its cross-sectional design and authors did not confirm class membership using follow-up 
predictor and covariate analyses. Instead, conclusions were drawn from inspection of LCA 
profile plots rather than empirical statistics. 
Two studies aimed to improve the prediction of conversion by investigating the latent 
subgroups among CHR individuals and their associations with subsequent conversion, and these 
studies found mixed results (Valmaggia et al., 2013; Velthorst et al., 2013). Velthorst et al. 
(2013) used a modified latent class factor analysis, a combination of factor analysis and LCA, to 
investigate latent classes underlying the symptom profiles of 288 CHR and healthy control 
participants. Using a model that investigated how latent classes cluster based upon the 
continuous latent factor of subthreshold symptom severity, two distinct latent classes emerged: 
an “at risk” and a “healthy class.” The emergence of two qualitatively different latent classes 
served to separate CHR individuals from healthy controls, but did little to enhance prediction of 
subsequent conversion.  Thus, Velthorst et al. (2013) were unable to find a relationship between 
symptom constellations and conversion. One possible reason for this finding is the inclusion of 
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healthy controls with limited variability. Another issue is the limited diversity of predictive 
indices, which may have hindered the study’s ability to ascertain vulnerability profiles.    
Valmaggia et al. (2013) applied a LCCA approach to a sample of 318 CHR individuals’ 
CAARMS ratings. The LCCA model sought to clarify the constellation of CAARMS symptoms 
that was most likely to precede the onset of psychosis. A 4-class model emerged, each associated 
with different risks of conversion to psychosis (class 1, 4.9%; class 2, 10.9%; class 3, 11.4%, 
class 4, 41.2%). The subgroup with the highest conversion risk (class 4) was characterized by the 
highest symptom ratings, lowest overall functioning score, and highest proportion of 
unemployed individuals. The four classes could be best separated by differences in negative 
symptom ratings (e.g., anhedonia, alogia, avolition) and behavioral change indices (impaired role 
functioning, social isolation), indicating that these variables are useful in determining who is at 
risk. Items measuring depression, anxiety, or impaired tolerance to normal stress could not 
differentiate risk groups, as the entire CHR sample reported high scores in these domains. Thus, 
the LCCA model was able to identify individuals with a specific constellation of negative 
symptoms and role impairments that were associated with a higher risk of conversion. 
The present paper seeks to extend previous latent variable method findings through the 
application of LPA in a large group of prospectively identified CHR individuals. Clinical and 
neurocognitive indices will be used to generate latent subgroups, and other demographic and 
clinical indices will be used to further characterize LPA subgroups. As such, the subsequent 
sections will refer to “indicators” and “covariates” in exploring possible variables for 
consideration in the model. “Indicators” are indices to be included in the LCA model to generate 
subgroups; whereas, “covariates” are indices used to further characterize associated features of 
the subgroups. 
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Predictors of Conversion to Psychosis 
 
A significant goal in CHR research over the past decade has been to determine who will 
convert from a CHR state to a full-blown psychotic disorder in prospective, longitudinal studies 
of CHR individuals. To this end, several clinical trials and longitudinal cohort studies have 
investigated predictors of conversion among help-seeking individuals meeting CHR criteria.  Of 
note, current conversion estimates and predictive models are generated from samples of 
distressed, impaired, help-seeking individuals who likely have a higher risk of developing 
psychosis than individuals randomly sampled in the general population. The number of 
individuals who meet criteria for CHR in the general population remains undetermined (Fusar-
Poli, Borgwardt, et al., 2013). Thus, present CHR criteria is based upon and validated among 
individuals that present to treatment clinics. 
The subsequent text will synthesize the existing literature prospectively exploring the 
predictive validity of clinical and functional characteristics and neurocognitive features. As CHR 
symptom criteria provides limited specificity in identifying who will likely convert to psychosis, 
research continues to employ a “close in” strategy, adding additional risk factors to the model to 
enhance predictive power (Bell et al., 1992). Of particular interest are prospective CHR studies 
with large samples (n ≥ 60) incorporating a broad range of indices in a stepwise multilevel 
assessment (Riecher-Rössler et al., 2009). When available, data from meta-analytic reviews will 
be included. The findings of such work informed the selection of clinical indices for inclusion in 
the present study’s model as indicators and covariates. 
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Clinical Characteristics 
 Initial studies predicting conversion included individuals meeting CHR symptom criteria 
(e.g., APS criteria), BS (e.g., COGDIS criteria), or a combination of the two. Each of the 
following studies’ models included different domains of interest and associated psychometric 
instruments. This has resulted in the generation of distinct predictive models that are difficult to 
synthesize. All studies used Cox logistic regression, unless otherwise specified.  
The Cologne Early Recognition study found that the presence of a specific constellation 
of BS symptoms (i.e., including thought interference, visual distortions, and disturbances in 
receptive language) predicted a diagnosis of schizophrenia within 10 years with a probability of 
91% (Klosterkötter, Hellmich, Steinmeyer, & Schultze-Lutter, 2001). Importantly, 96% of 
individuals with an absence of BS did not go on to develop schizophrenia. A recent review of 
prospective studies using BS found that COGDIS criteria predicted the onset of first-episode 
psychosis as well as CHR criteria (Schultze-Lutter et al., 2012). Further, meta-analytic findings 
indicated the addition of individuals meeting BS criteria at baseline assessment was able to 
identify individuals that transitioned to schizophrenia specifically rather than other affective 
psychoses, providing support that the BS is associated with diagnostic specificity (Fusar-Poli, 
Bechdolf, et al., 2013). 
Yung and colleagues (2003) conducted the first prospective study of later phase 
prodromal CHR individuals. The model with the strongest predictive ability was derived from 
indices of subthreshold positive and negative symptoms, depressive symptoms, duration of the 
prodrome, baseline overall functioning, and specific symptoms of attention and disorganization 
(Yung et al., 2003). Mason et al. (2004) attempted to replicate Yung et al. (2003), and found an 
altered predictive model including the presence of schizotypal personality characteristics and 
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various symptoms at an item level. Items included those assessing odd beliefs, role functioning, 
blunted affect, anhedonia/asociality, and auditory hallucinations. Consistent through these 
models, as well as in findings from the Early Detection and Intervention Evaluation study, is the 
key role of attenuated positive symptoms in predicting later conversion (Morrison et al., 2004). 
This initial foundational work led to larger, longitudinal, multisite studies assessing predictors of 
conversion to psychosis. Three significant samples will be described in the subsequent text: the 
North American Prodrome Longitudinal Study (NAPLS; Addington et al., 2007), The Personal 
Assessment and Crisis Evaluation Program (PACE; Thompson, Nelson, & Yung, 2011), and 
Prospective European Prediction of Psychosis Study (EPOS; Ruhrmann et al., 2010).  
NAPLS prospectively followed 291 CHR individuals and found that five clinical 
predictive variables significantly accounted for unique variance in conversion. Predictive criteria 
included increased unusual thought content, increased suspiciousness and paranoia, social 
functioning impairment, history of substance abuse, and presence of genetic risk for 
schizophrenia with recent decline in overall functioning (Cannon et al., 2008). Contrary to what 
might be hypothesized given the relationship between cannabis, amphetamines, and psychotic 
symptom exacerbation, history of alcohol or drug abuse was a relatively weak predictor in this 
sample. Subsets of the five variables resulted in significantly enhanced predictive power (up to 
80%), but led to a higher rate of false negatives (Cannon et al., 2008). NAPLS is a foundational 
study in prospective prediction research and led to several replication studies. 
 Other research groups have provided further evidence for predictive relationships 
established in NAPLS. The Personal Assessment and Crisis Evaluation Program (PACE) was 
able to replicate findings using a subset of NAPLS indices, finding that unusual thought content, 
low overall functioning, and genetic risk for schizophrenia with recent decline in overall 
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functioning each uniquely predicted later conversion (PACE; Thompson, Nelson, et al., 2011). 
The Dutch Prediction of Psychosis (DUPS) study also sought to replicate NAPLS prediction 
model, finding that social anhedonia and social withdrawal were the two strongest predictors of 
subsequent onset (Velthorst et al., 2009). The Prospective European Prediction of Psychosis 
Study (EPOS) included individuals meeting CHR criteria and individuals meeting COGDIS 
criteria. EPOS results indicated that six variables best predicted conversion, including sleep 
disturbance, overall positive symptom score, bizarre thinking, schizotypal personality disorder 
diagnosis, overall functioning in the past year, and years of education (Ruhrmann et al., 2010). 
Of note, genetic risk for schizophrenia with recent decline in overall functioning was not 
predictive in the EPOS sample.  
Demjaha and colleagues (2012) sought to investigate a data-driven dimensional model of 
prediction through an exploratory factor analysis of clinical symptom scores to ascertain whether 
certain symptom dimension scores predicted subsequent conversion to psychosis better than 
others. Principal factor analysis yielded a five-factor solution comprised of negative, 
disorganization/cognitive, self-harm, anxiety, and manic symptom dimensions. Cox regression 
analyses were conducted using summed dimensional scores; results indicated that the negative 
and disorganized/cognitive symptom dimensions were most closely associated with subsequent 
conversion. 
While it is difficult to compare the utility of indices given that studies did not measure the 
same sets of variables, certain indices’ predictive validity have been well replicated and warrant 
summary. The utility of attenuated positive symptoms has been well established, including the 
positive symptom subscale total (Morrison et al., 2004; Ruhrmann et al., 2010; Yung et al., 
2003), unusual thought content/odd beliefs symptom ratings (Cannon et al., 2008; Mason et al., 
  15 
2004; Thompson, Nelson, et al., 2011; Ruhrmann et al., 2010), and suspiciousness/paranoia 
symptom ratings (Cannon et al., 2008; Cornblatt et al., 2015). While the general negative 
symptom subscale total has limited predictive power with only one early study supporting its 
utility (Yung et al., 2003), specific items measuring anhedonia (Mason et al., 2004; Velthorst et 
al., 2009), social dysfunction (Cannon et al., 2008), and withdrawal (Velthorst et al., 2009) 
appear to be predictive of conversion. Fairly consistent evidence is in support of the utility of 
overall functioning indices (Ruhrmann et al, 2010; Thompson, Nelson, et al., 2011; Yung et al., 
2003) as well as overall decline in functioning combined with genetic risk (Cannon et al., 2008; 
Thompson, Nelson, et al., 2011). Though BS research is more limited, results generally favor the 
two-stage model of early and late prodromal phase as assessed by BS and CHR, respectively 
(Klosterkötter et al., 2001; Klosterkötter et al., 2011). Further, work suggests that using both BS 
(e.g., COGDIS criteria) and CHR criteria enhances prediction of conversion (Ruhrmann et al., 
2010).  
Mood Symptoms 
 It is well accepted that affective symptoms co-occur with subpsychotic symptoms in the 
prodrome (Yung et al., 2008; Woods et al., 2009). In a retrospective accounting of symptoms, a 
majority of individuals with schizophrenia (73%) reported a prodromal phase consisting of 
negative symptoms and non-specific affective symptoms lasting an average of five years (Häfner 
et al., 1992). A study further investigating the chronology and course of depressive symptoms in 
a sample of adolescent-onset CHR individuals found that depressive symptoms occur at the 
earliest stage of the prodrome, earlier than the onset of first CHR positive symptoms (Myles-
Worsley, Weaver, & Blailes, 2007; Schultze-Lutter, Rurhmann, Berning, Maier, & Klosterkötter, 
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2010). Further, they found that depressive symptomatology evidenced a linear increase over time 
among individuals that later converted to psychosis (Schultze-Lutter et al., 2010).  
While the association of depression and CHR symptoms is well established, findings are 
more mixed regarding depressive symptoms and mood diagnoses’ ability to predict subsequent 
conversion to psychosis. A recent meta-analysis (k = 11) found that the presence of comorbid 
depressive and anxiety disorders did not predict subsequent conversion to psychosis over the 
course of 3.65 years (Fusar-Poli, Nelson, et al., 2014). Instead, authors theorized that mood and 
anxiety disorders interact with and have causal impact on CHR symptoms, which may eventually 
lead to transition to psychosis and functional decline (Fusar-Poli, Nelson, et al., 2014). This is 
consistent with findings from NAPLS, where diagnostic comorbidity, depression symptoms, and 
mania symptoms did not differentiate converters from nonconverters (Cannon et al., 2008; 
Cornblatt et al., 2012). However, findings from the large scale longitudinal EPOS study (n = 
245) found that while several axis I mood and anxiety disorders were prevalent among CHR 
individuals, comorbid bipolar or unipolar mood disorders predicted conversion to psychosis 
while anxiety disorders did not (Ruhrmann et al., 2010). Similarly, Michel et al. (2014) found 
that converters and nonconverters could be differentiated by baseline presence of recurrent brief 
depressive disorder. Taken together, while findings predicting conversion from the presence of 
symptoms of depression and mania are mixed, such symptoms may characterize the early 
prodromal stage and function as a component in a larger constellation of symptoms (Myles-
Worsley, Weaver, & Blailes, 2007; Schultze-Lutter et al., 2010). Alternatively, the prodromal 
phase of bipolar disorder and psychotic spectrum illness share some degree of positive and 
general symptomatology (e.g., grandiosity, perceptual abnormalities, sleep difficulties; Olvet et 
al., 2010) and may evidence a similar pattern of neurocognitive impairment after illness onset 
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(Bora & Pantelis, 2015). While work regarding incidence rates of psychosis vs. other psychiatric 
disorders in CHR groups is limited, recent findings indicated that emergent psychosis diagnoses 
were significantly more likely than any nonpsychotic disorder diagnoses in CHR individuals 
(Webb et al., 2015). 
Neurocognitive Ability 
Neurocognitive deficits are regarded as a hallmark feature of schizophrenia (Heinrichs, 
2005). In the psychosis literature, neurocognitive ability may be understood as 
neuropsychological performance on a number of different subdomains, including memory, 
attention, verbal fluency, executive functioning, and psychomotor performance (Marder, Fenton, 
& Youens, 2004). In the Diagnostic and Statistical Manual of Mental Health Disorders (DSM-5) 
section III, “impaired cognition” was proposed to be one of eight dimensions of psychosis 
symptom severity (APA; 2013). The extant literature uses both standardized subdomain scores 
and composite neurocognition scores (i.e., full scale IQ) in models predicting conversion from 
baseline neurocognitive ability.  
A recent meta-analysis found that CHR individuals evidenced small to medium 
neurocognitive deficits when compared to healthy controls, across neurocognitive domains 
(Fusar-Poli, Deste, et al., 2012). A notable exception is IQ score, as estimates of general IQ 
appeared not to differentiate between converters and nonconverters (Giuliano et al., 2012). The 
longitudinal research on neurocognitive predictors is still in a nascent stage. Across the extant 
longitudinal literature comparing baseline neurocognitive deficits of converters and 
nonconverters, the most promising candidate predictors of subsequent conversion appear to be 
processing speed, verbal memory, verbal fluency, visual memory, and working memory (De 
Herdt et al., 2013; Fusar-Poli, Deste, et al., 2012; Keefe et al., 2006; Lin et al., 2013; Pukrop et 
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al., 2007). However, such work does not consider interactions between clinical symptom criteria 
and neurocognitive ability. 
Of particular interest are studies investigating the predictive validity of neurocognitive 
deficits in regression models by incorporating a broad range of indices measuring both clinical 
symptomatology and neurocognitive ability (Cornblatt et al., 2015; Keefe et al., 2006; Riecher-
Rössler, 2009; Seidman et al., 2010). Früherkennung von Psychosen used a predictive model 
including indices of executive functioning, working memory, attention, and general ability in 
combination with basic clinical symptomatology indices. The predictive model with the strongest 
sensitivity and specificity included items measuring suspiciousness, anhedonia/asociality, and 
performance on a measure of executive functioning (Riecher-Rössler et al., 2009). The NAPLS 
team has also explicated the relationship between baseline neurocognitive performance and 
subsequent conversion to psychosis, finding that impairments were more significant in 
converters than in nonconverters, but only modestly (composite neurocognitive score, d = 0.40) 
(Seidman et al., 2010). At a domain level, lower baseline verbal memory predicted time to 
conversion such that it was associated with more rapid conversion. Cox regression models 
incorporating neurocognitive indices in the prior multivariate NAPLS prediction model (Cannon 
et al., 2008) found that neurocognitive indicators did not uniquely predict psychosis beyond 
clinical indices. Conversely, a recent study by Cornblatt et al. (2015) found that impaired verbal 
memory enhanced a risk model including other clinical variables. Thus, evidence is mixed 
regarding the utility of neurocognitive indices as compared to other clinical indices. 
European researchers have probed neurocognitive impairments among different theorized 
phases in the prodrome using both COGDIS and CHR criteria (Frommann et al., 2010; Michel et 
al., 2014). Frommann et al. (2010) found that the early phase prodrome is characterized by 
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deficits in executive control/processing speed, greater than and independent from deficits in 
other domains (Cohen’s d ~ 0.50). The later phase prodrome is characterized by verbal memory 
deficits, executive control/processing speed, and to a lesser degree, working memory deficits. 
Working memory was intact in the early phase prodrome. Thus, it is theorized that deficits in 
executive control/processing speed predate first subthreshold positive symptoms, while the 
introduction of verbal memory impairment in later prodrome marks a disease progression. While 
these data do not shed light on differences between converters and nonconverters, findings 
indicate that progressive neurocognitive impairment co-occurs with psychotic disease 
progression (Frommann et al., 2010).  
A more recent study extended the investigation of Frommann and colleagues (2010) with 
comparisons of converters and nonconverters and Cox regression modeling to stratify risk level 
using both clinical and neurocognitive variables (Michel et al., 2014). Further, neurocognitive 
deficits were defined relative to age normed data, such that deficits on neurocognitive domains 
were entered categorically into the predictive model (present, absent). This model found that the 
risk of conversion was highest in the presence of concomitant factors of APS criteria, COGDIS 
criteria, and a processing speed deficit as measured by the digit symbol test.       
In summary, while meta-analytic studies have indicated that CHR individuals can be 
characterized by significant deficits across all domains of neurocognition, specific domains 
appear to be predictive of subsequent conversion to psychosis. Neurocognitive domains that 
show the strongest ability to predict conversion in models including broader clinical variables are 
executive functioning (Riecher-Rössler et al., 2009), verbal memory/fluency (Cornblatt et al., 
2015; Seidman et al., 2010), and processing speed (Frommann et al., 2010). Further, some work 
suggests that the early and late prodrome are characterized by different profiles of 
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neurocognitive deficits, with early deterioration in processing speed ability and working memory 
deficits occurring just before onset of frank psychosis (Frommann et al., 2010). 
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Covariates Characterizing CHR Subgroups 
 
Social Cognition 
Social cognition (SC) is best defined as a set of neurocognitive processes related to 
understanding, recognizing, processing, and appropriately using social stimuli in one’s 
environment (Adolphs, 2009; Penn, Corrigan, Bentall, Racenstein, & Newman, 1997). Social 
cognition is a multi-faceted construct consisting of several sub-domains. Domains of interest in 
the present study include emotion perception (EP; the ability to perceive and appropriately use 
emotions) and theory of mind (ToM; the ability to infer others’ mental states) (Pinkham et al., 
2013).  
There is evidence that as compared to healthy controls, CHR individuals have deficits in 
some domains of SC more than others (Thompson, Bartholomeusz, & Yung, 2011; van 
Donkersgoed et al., 2015). Specifically, a meta-analysis showed medium effect sizes differences 
between CHR and healthy controls in both ToM and EP (g = 0.43 - 0.45). In comparisons 
between converters and nonconverters, ToM also evidenced a medium effect size (g = .63), with 
converters showing significant impairment compared to nonconverters (Lee et al., 2015). Recent 
findings from baseline measures of the NAPLS 2 cohort found evidence of significant 
impairment in ToM and EP in CHR individuals, but the EP deficits did not remain statistically 
significant when controlling for age and IQ (Barbato et al., 2015). Thus, evidence suggests that 
social cognitive impairments begin during early phases of illness and are differentially associated 
with basic neurocognition. Regarding whether performance on tasks of SC enhances predictive 
models of conversion to psychosis, some work suggests that baseline ToM deficits are predictive 
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of later conversion (Healey, Penn, Perkins, Woods, & Addington, 2013; Kim et al., 2011). These 
models remained significant even after the addition of neurocognitive predictor variables. 
Conversely, other work indicates that baseline ToM performance is not predictive of psychosis 
(Gill et al., 2014). Thus, evidence is mixed in support of SC’s predictive validity in CHR 
individuals. 
Meta-analytic findings indicate SC is more proximal to functional outcome than 
neurocognition in individuals with schizophrenia spectrum illnesses (Fett, Viechtbauer, Penn, 
van Os, & Krabbendam, 2011). This underlines the importance of investigating SC in CHR 
individuals as a potential treatment target to mitigate functional decline. Thus far, only two 
studies have explored associations between neurocognition, social cognition, and social 
functioning in CHR individuals (Addington, Saeedi, & Addington, 2006; Barbato et al., 2013b). 
Addington et al. (2006) found that SC mediates the relationship between neurocognition and 
social functioning. Barbato and colleagues (2013) attempted to replicate this finding, with results 
suggesting there is a stronger relationship between social cognition and social functioning than 
neurocognition and social functioning. However, SC did not predict social functioning in a 
regression model (Barbato et al., 2013b). Further work is thus needed to determine SC’s role in 
CHR individuals and relationship with long term functioning. 
Internalized Stigma 
 It has been argued that labeling young people at risk of developing psychosis may result 
in internalized stigma and discrimination similar to that associated with a psychotic disorder 
diagnosis (Yung, Nelson, Thompson, & Wood, 2010). Recent work has supported this, 
indicating that an individual with a hypothetical “at-risk” diagnosis evoked greater negative 
stereotyping than individuals with other, non-psychotic diagnoses (Yang et al. 2013). Measures 
  23 
of internalized stigma have been validated in CHR individuals with success, and this construct 
has shown significant associations with depression, social anxiety, and suicidal thinking (Pyle et 
al., 2015). Using the sample of CHR individuals from the present data set, Stowkowy and 
colleagues (2015) found that a subscale of items concerning an absence of “control over 
experiences” was associated with conversion to a psychotic disorder (e.g., “I am powerless over 
my experiences”). This is consistent with other work that has found that “self-disturbance,” or a 
disruption in basic sense of self, is a phenotypic marker of psychotic spectrum illness 
vulnerability. Disruptions in “mineness” of one’s mental content (i.e., feeling that one’s thoughts 
are his/her own) are disrupted in later phases of the prodrome, and is predictive of later transition 
to psychosis (Nelson, Thompson, & Yung, 2012). Thus, negative beliefs about illness and 
associated internalized stigma affect course, chronicity, and may be linked to conversion to a full 
psychotic disorder. 
Substance Use 
 The harmful effect of substance use in early psychosis is well established with evidence 
linking substance abuse in first-episode psychosis with significantly greater hospitalizations 
(Haywood, Kravitz, Grossman, & Cavanaugh, 1995) and increased rates of relapse (Malla et al., 
2008). Conversely, literature regarding substance use (e.g., alcohol, cannabis, methamphetamine) 
in CHR individuals is very limited. Some work indicates that cannabis and methamphetamine 
usage in adolescence incurs a higher risk of developing schizophrenia (Callaghan et al., 2012; 
Kuepper et al., 2011). Causality of this relationship is debated, as drug use appears to but one 
component in a constellation of predictors resulting in transition to psychosis (e.g., Arsenault-
Lapierre, Kim, & Turecki, 2004). Prospective studies following CHR individuals over time may 
clarify the role of substance use this vulnerable stage, however this literature is currently very 
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limited. Substance abuse data is not routinely measured or incorporated in predictive models, and 
at times individuals meeting substance dependence criteria are excluded from studies to protect 
validity of neurocognitive data (Addington, Case, et al., 2014). 
 Of the studies addressing conversion to psychosis, evidence supporting the predictive 
validity of indices related to substance use is weak. As previously mentioned, results from 
NAPLS indicated that history of substance use disorder predicted conversion with other indices, 
though it was not as strong as other clinical predictors (Cannon et al., 2008). Other large 
longitudinal studies found that substance abuse was not predictive of conversion to psychosis 
(Auther et al., 2012; Buchy et al., 2015; Ruhrmann et al., 2010) or social/role functioning 
(Auther et al., 2012). Of note, a study using the same data set as the present study found that low 
alcohol use predicted subsequent transition, but no other substances at baseline (Buchy et al., 
2014). A recent meta-analysis suggested that there is a dose-response relationship between 
cannabis use and conversion to psychosis, such that current use (i.e., dependence or abuse), but 
not lifetime cannabis use increased risk of conversion (Kraan et al., 2015). The complicated 
relationship among substance use and onset of psychosis indicates further prospective 
investigation may be needed. 
Racial and Ethnic Background 
 Immigrant and visible minority status is associated with an increased risk of developing 
psychotic spectrum illnesses (e.g., meta analyses: Bourque, Van der Ven, & Malla, 2011; 
Cantor-Graae & Selten, 2005). African American individuals are three times as likely as 
Caucasians to receive diagnoses of schizophrenia, and twice as likely after controlling for 
socioeconomic status (Bresnahan et al., 2007). When compared to the majority population, 
ethnic minorities are found to have higher rates of schizophrenia spectrum illnesses but lower 
  25 
rates of bipolar spectrum disorders (Amad et al., 2013; Veldhuizen, 2009). It has been theorized 
that ethnic minority status incurs specific risk for psychotic disorders. Numerous hypotheses are 
postulated to explain potential causes, including (1) incorrect diagnosis of psychotic disorders in 
minorities based on race/ethnicity and/or cultural misinterpretations (Barnes, 2008), and (2) 
visible minority status leading to increased experiences of discrimination (Berg et al., 2014). 
Increased perception of discrimination is associated with greater depressive, positive, and 
delusional symptoms (Berg et al., 2014; Janssen et al., 2003). In individuals with chronic 
schizophrenia, recent work has investigated the symptom profiles of visible minorities versus all 
other patients, and has found that visible minorities had significantly higher scores on items 
measuring delusions and difficulty in abstract thinking (Berg et al., 2014). 
 It follows then, that increased perception of discrimination associated with one’s visible 
minority status may be associated with increased symptomatology and risk of conversion in the 
CHR population. While associations between perception of discrimination and transition to 
psychosis have not yet been explored, there is some evidence that individuals at CHR experience 
greater discrimination than healthy controls. However, such perceived discrimination was not 
related to belonging in an ethnic minority group or identifying as an immigrant (Saleem et al., 
2014). Research regarding perceived discrimination and racism in particular is in an early stage, 
as studies tend to match CHR and healthy control groups on racial/ethnic minority status or 
employ other methodologies to statistically control for the effect of race. It is possible that visible 
minority status incurs increased risk and specific constellations of symptoms. Subgroup analyses 
may shed light on such differences. 
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Premorbid Functional Ability 
 Functional impairment is a key feature in the phase prior to onset of frank psychosis, as 
established by studies of first-episode psychosis (MacBeth & Gumley, 2008). Functional 
deterioration is associated with an earlier age of onset and poorer general prognosis in 
individuals with established psychotic disorders (e.g., Strous et al., 2004). While evidence 
supports the predictive validity of indices of baseline functioning in CHR individuals (e.g., 
Cannon et al., 2008: Mason et al., 2004; Ruhrmann et al., 2010; Thompson, Nelson, et al., 2011; 
Yung et al., 2003), less work has focused on the predictive validity of premorbid functioning. 
Premorbid functioning may be defined as functional ability predating the onset of CHR, across 
different developmental periods (i.e., childhood). 
Two studies from the NAPLS sample prospectively investigated the association between 
deterioration of functioning in the premorbid phase and conversion to psychosis (Tarbox et al., 
2013; Tarbox et al., 2014). The Premorbid Adjustment Scale (PAS; Brill, Reichenberg, Weiser, 
& Rabinowicz, 2008; Cannon-Spoor, Potkin, & Wyatt, 1982) was used to assess premorbid 
adjustment in social, academic, and overall functioning across four periods of development (age 
five to adulthood). Comparisons between converters and nonconverters indicated that converters 
evidenced significantly higher ratings of social maladjustment in early adolescence (age 12-15). 
After controlling for baseline subthreshold psychotic symptoms, early adolescent social 
maladjustment continued to uniquely predict conversion over and above all included symptoms. 
Further, the strongest predictive model including an array of clinical symptoms was comprised of 
ratings of early adolescent social maladjustment and suspiciousness (Tarbox et al., 2013). An 
extension of this study found that social maladjustment in late adolescence (15-18) predicted 
transition specifically to schizophrenia rather than other psychotic spectrum illnesses (Tarbox et 
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al., 2014). This work is corroborated by findings from the Copenhagen Perinatal Cohort study, 
which found that teacher-rated measures of social functioning at age 10-13 predicted later 
transition to psychosis (Tsuji et al., 2013). Thus, social maladjustment from early and late 
adolescence appears to confer unique risk beyond academic and total maladjustment ratings. 
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Functional Trajectory 
 
While conversion to psychosis has assumed primacy in early detection and intervention 
studies, it is becoming increasingly clear that functional outcome is worthy of investigation. 
CHR individuals that do not go on to convert to a psychotic disorder often continue to experience 
significant impairment in social and role functioning (e.g., Addington et al., 2011; Schlosser et 
al., 2012). However, much less is known of nonconverters, as a systematic review indicated 
nearly half of CHR studies did not provide relevant characteristics of nonconverters (Simon et 
al., 2011). In the field of CHR research, functioning is typically parsed into social, role, and 
global functioning, though there is conceptual overlap between these areas. Social functioning 
may be defined as competencies related to interpersonal communication, independence in 
activities of daily living, social activities and recreation (Birchwood, Smith, Cochrane, Wetton, 
& Copestake, 1990). Role functioning may be defined as instrumental role functioning (e.g., role 
of student, housekeeper, worker), interpersonal relations, and common activities/hobbies. 
 Of interest is the degree to which functional outcome is independent from conversion to 
psychosis in CHR groups. If conversion and functional outcome are redundant, there is no utility 
in further exploring of indices associated with functional outcome. While functioning indices are 
predictive of subsequent conversion to psychosis (e.g., Cannon et al., 2008; Thompson, Nelson, 
et al., 2011; Ruhrmann et al., 2010), less work has investigated whether conversion status is 
predictive of later functional decline in the full CHR sample. This is clinically relevant; if the 
constellation of factors contributing to poor role and social functioning is different from those 
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contributing to conversion to a full psychotic disorder, then such symptom constellations may 
also be prioritized as treatment targets. 
Prospective studies including conversion status in models predicting subsequent 
functional outcome have explicated this relationship with mixed findings. Carrión et al. (2013) 
included conversion status in a model predicting social and role outcome from indices measuring 
symptoms and neurocognition. Role outcome was independent of conversion to psychosis, 
however social outcome was significantly related to conversion. Findings from the EPOS study 
indicate that approximately one third of the CHR group experienced poor psychosocial outcome, 
and that conversion to psychosis did not explain functional outcome (Salokangas et al., 2013). 
Salokangas et al. (2014) found that conversion status was significantly associated with poor 
functioning at follow-up as measured by the GAF. However, the GAF includes assessment of 
symptoms, and thus may not be as valid of a measure as other, more specific role/social 
functional measures.  
Though results are mixed, they indicate that conversion and associated symptomatology 
do not fully account for poor functional outcome in CHR individuals. A recent systematic review 
revealed that irrespective of conversion to psychosis, individuals with a history of negative 
symptoms, disorganized symptoms, and cognitive deficits predating the onset of frank psychosis 
are more likely to have impaired long term functioning (Cotter et al., 2014). Thus, it is useful to 
investigate variables apart from conversion status, such as symptom constellations and other 
clinical features, in order to better explicate contributors to subsequent functioning. 
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The Present Study 
 
The present study aimed to build upon Valmaggia and colleagues’ (2013) model, which 
included only subthreshold psychotic symptoms as measured by the CAARMS and a single 
overall functional index as measured by the GAF. Their study is limited by the narrow scope of 
indicators and covariates, such as lacking specific measures of functioning (e.g., social, 
occupational), neurocognition, and pre-morbid functioning, all of which are associated with later 
conversion to psychosis in regression models. The present study sought to enhance the validity 
of the latent model by adding diagnostically relevant clinical and neurocognitive indices as 
indicators. The current study aimed to extend prior LCA models through the exploration of the 
functional trajectory of each latent subgroup. Additionally, the current study sought to further 
characterize latent subgroups with regard to social cognitive ability, premorbid functioning, 
internalized stigma, substance use, and racial/ethnic composition. 
Aims & Hypotheses 
Aim 1: Evaluate the latent profile structure of the CHR group. The first aim was to 
evaluate the latent profile structure of the CHR group using LPA. As previously discussed, CHR 
groups are diagnostically heterogeneous, composed of individuals presenting with various 
clusters of symptoms (e.g., affective symptoms, anxiety symptoms, subpsychotic symptoms) 
(e.g., Salokangas et al., 2012). It is likely that there are subgroups hidden within the 
heterogeneous CHR group, each associated with different constellations of symptoms and 
associated probabilities of conversion. LPA models ascertain such subgroups and thus may 
provide a more accurate model of who is truly at risk of developing schizophrenia, resulting in a 
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clinically useful profile of risk indicators. As the current study is a data driven statistical model, 
the number and size of classes were not known a priori (Collins & Lanza, 2010).  
Hypothesis: It was hypothesized that LPA methods will reveal homogenous subgroups from the 
psychopathologically heterogeneous sample. The number and size of classes were not 
hypothesized. 
Aim 2: Evaluate the risk probability of conversion to a psychotic disorder in each 
latent class. The second aim was to evaluate the probability that each latent class would later 
convert to a full psychotic disorder (see definition of “conversion” in methods). Hypothesis: It 
was hypothesized that the subgroup associated with the highest risk of conversion would include 
high ratings of: attenuated positive psychotic symptoms (e.g., Yung et al., 2003), unusual 
thought content (e.g., Cannon et al., 2008), suspiciousness (e.g., Cannon et al., 2008), social 
anhedonia (e.g., Velthorst et al., 2009), occupational functioning impairment (e.g., Mason et al., 
2004), and neurocognitive impairment (e.g., processing speed, verbal memory, verbal fluency, 
and working memory) (e.g., Frommann et al., 2010; Riecher-Rössler et al., 2009; Seidman et al., 
2010). There is currently insufficient evidence to hypothesize what constellation of symptoms 
would characterize latent classes associated with a lower risk of conversion. 
Aim 3: Evaluate indicators’ importance in the clustering process. The third aim was 
to examine the indicators’ respective contributions to subgrouping. This enables characterization 
of differences and response patterns among the subgroups, and specifically what patterns of 
indicators drove the LPA clustering process. Hypothesis: It was hypothesized based upon prior 
work (Valmaggia et al., 2013) that negative symptoms (e.g., SOPS negative symptom subscale) 
would be the most influential in the LPA modeling process. Further, it was hypothesized based 
on extant work using logistic regression that neurocognitive indices (i.e., verbal memory and 
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processing speed) would also be influential in the LCA modeling process (e.g., Frommann et al., 
2010; Riecher-Rössler et al., 2009; Seidman et al., 2010). 
Aim 4: Evaluate covariates to further characterize subgroups. The fourth aim was to 
examine associations between covariates and subgroup membership. Covariates of interest have 
demonstrated patterns of association with the CHR state that warrant further exploration, 
including social cognition, internalized stigma, substance use, and racial ethnic minority status. 
Further, prodromal clinic site (Toronto, UNC, Yale) was included as a covariate to assess 
potential site effects. Hypothesis: It was hypothesized that the subgroup associated with the 
highest risk of conversion would be further characterized by impairment in ToM, decreased 
control over experiences, recent cannabis and alcohol abuse, poor premorbid functioning, and 
racial ethnic minority status (e.g., Bourque et al., 2011; Callaghan et al., 2012; Healey et al., 
2013; Kim et al., 2011; Nelson et al., 2012; Tarbox et al., 2013). 
Aim 5: Evaluate the functional trajectory of subgroups, and compare subgroups on 
functioning over time. The fifth aim was to examine the functional trajectory of each subgroup 
over time. CHR individuals that do not go on to convert to a psychotic disorder often continue to 
experience significant impairment in social and role functioning (e.g., Addington et al., 2011; 
Schlosser et al., 2011). Current research indicates that conversion and associated psychotic 
symptomatology do not fully account for poor functional outcome in CHR individuals 
(Salokangas et al., 2013; Salokangas et al., 2014). Hypothesis: It was hypothesized that 
subgroups would evidence significant between group differences across time points on 
functional indices, and that subgroups would evidence significant within group change over time. 
Exploratory Aims  
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Exploratory Aim 1: Evaluate the covariates that best predict subgroup membership. 
Since no current work has explored the set of indices that best predicts subgroup membership 
given our predictive model, this exploratory aim served to examine covariates that best predict 
subgroup membership. This is a worthwhile endeavor, as such analyses will encourage further 
exploration and characterization of subgroups.  
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Methods 
 
Sample 
 The sample consisted of 171 participants (98 males, 73 females) at CHR of developing 
psychosis with a mean age of 19.8 (SD = 4.5) and 100 help-seeking control (HSC) participants 
(56 males, 44 females) with a mean age of 19.4 (SD = 3.9) years. All data were collected as a 
part of NIMH funded, multi-site study “Enhancing the Prospective Prediction of Psychosis” 
(PREDICT). Several studies have been published using this data set (Addington et al., 2008a; 
Addington et al., 2008b; Addington et al., 2012; Addington & Barbato, 2012; Barbato et al., 
2013a; Barbato et al., 2013b; Barbato et al., 2014; Buchy et al., 2014; Callaway et al., 2014; 
Couture et al., 2008; Hawkins et al., 2008; Healey et al., 2013; Lyngberg et al., 2015; Stowkowy 
et al., 2015; Stowkowy & Addington, 2012; Yong et al., 2014). 
  PREDICT was conducted at the Universities of North Carolina at Chapel Hill (UNC-CH; 
62 CHR, 24 HSC), Toronto (69 CHR, 45 HSC), and Yale (40 CHR, 31 HSC). All CHR 
participants met Criteria of Prodromal Syndromes (COPS) derived from the Structured Interview 
for Prodromal Syndromes (SIPS: McGlashan et al., 2010). The majority of CHR participants (n 
= 168) met criteria for attenuated positive syndrome (APS). Six participants met criteria for 
genetic risk and deterioration (GRD), which requires either an affected first degree relative or the 
participant having schizotypal personality disorder and a 30% drop in functioning on the General 
Assessment of Functioning (GAF) scale in the past 12 months. Schizotypal personality disorder 
has evidenced a genetic relationship to schizophrenia in samples of twins, adoptees, and first-
degree family members (e.g., Kendler, Gruenberg, and Strauss, 1981). 
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 The help-seeking control group (HSC) was comprised of individuals who had (1) 
responded to CHR recruitment and (2) presented with prodromal symptoms at phone screen but 
upon administration of the full interview did not meet prodromal criteria. The HSC group 
contains the following subgroups: (1) family high risk but no deterioration in GAF (n = 16) (2) 
long-standing attenuated symptoms present for 1 year (n = 39) (3) current prodromal symptoms 
but symptoms were clearly due to another disorder (n = 2) (4) had only negative symptoms (n = 
4) and (5) symptoms that did not meet severity or frequency criterion (n = 24). HSC individuals 
were included as a clinically relevant control group that provides a more stringent test of 
conversion, as CHR and HSC individuals are more symptomatically similar to one another than 
to non-psychiatric controls.  
 The Structured Clinical Interview for DSM-IV (SCID-I: First, Spitzer, Gibbon, & 
William, 1996) was administered to determine the presence of any axis I disorders. Exclusion 
criterion consisted of any of the following criteria: presence of an axis I psychotic disorder, IQ 
less than 70, or a past or current of a clinically significant central nervous system disorder that 
may contribute to or confound CHR symptoms. Individuals were also excluded for past or 
current use of antipsychotic medication, as the PREDICT study aimed to examine predictors of 
conversion to psychosis without the confound of antipsychotic medications. After conducting 
comprehensive clinical assessments to determine inclusion, participants completed other 
measures and tasks.  
Procedures 
The PREDICT study was a longitudinal study of predictors of conversion to psychosis. 
Study protocols and informed consent documents were reviewed and approved by the 
institutional review boards of the three participating study sites (UNC-CH, University of 
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Toronto, Yale University). Formal consenting procedures were conducted with all participants. 
Testing occurred over two sessions, typically on the same day but consistently within seven days. 
Participants were assigned a clinical rater who administered all semi-structured interviews with 
that participant. Raters at all three sites underwent a training program developed at Yale to 
properly identify the prodromal syndrome with adequate reliability (Miller et al., 2003). All 
raters were experienced research clinicians who demonstrated adequate reliability through the 
administration of routine reliability checks. Gold standard post-training agreements on the 
discrimination between high risk (5) and psychotic (6) levels of intensity on the positive 
symptom items (the critical threshold for determining both initial eligibility and subsequent 
conversion status) were excellent (kappa = 0.90).  
The DSM-IV diagnoses were established with the SCID-I. Interrater reliability was 
determined at the start of the study and subsequent annual retesting by 100% agreement on the 
diagnosis and at least 80% agreement for symptom presence. JA chaired weekly conference calls 
to review inclusion criteria for all CHR individuals that participated the study. JA trained 
research assistants in neurocognitive assessments and DP trained research assistants in social 
cognitive assessments.  
Follow-up Assessments 
All participants were contacted to return for follow-up assessments at six-month intervals 
over the course of five years. The primary outcome variable for this study was time from initial 
evaluation to conversion to psychosis according to SIPS/SOPS criteria. Given significant 
attrition, longitudinal functional data will be used from the first two years of testing only. 
Conversion data is provided from the full five years. See Appendix A for a full schedule of 
assessments and Appendix B reason for dropout by subgroup (CHR and HSC). 
  37 
Measures 
 Symptom measures 
Clinical high risk (CHR) symptomatology and criteria. Prodromal syndrome and 
conversion criteria were assessed using the SIPS (McGlashan et al., 2010). The SIPS interview 
assesses information concerning the presence and severity of 19 distinct symptoms of the Scale 
of Prodromal Symptoms (SOPS), each rated on a 7-point scale (0-6), with higher ratings 
indicating symptomatology associated with greater intensity and frequency. The prodromal range 
is generally considered to lie between scores of 3-5, corresponding with anchors moderate-severe 
(Corcoran et al., 2011). The SOPS symptoms are categorized across four domains of 
psychopathology, including negative, positive, disorganized, and general symptoms, and can be 
summarized accordingly for total domain scores (Miller et al., 2003).  
 The SIPS also assesses information concerning family history, schizotypal personality 
disorder, and global functioning. Results of SIPS interview are integrated to determine the 
threshold presence of prodromal syndromes. Three prodromal syndromes are operationally 
defined, including attenuated positive symptoms syndrome, genetic risk and deterioration 
syndrome, and brief intermittent psychotic symptoms. The attenuated positive symptoms 
syndrome (APS) consists of the presence of at least one positive symptom (e.g., suspiciousness 
or grandiose ideas), but not at a level at or exceeding psychotic (≥ 6). Genetic risk and 
deterioration symptoms syndrome consists of a combination of both functional decline and 
genetic risk status. Genetic risk is defined by having either schizotypal personality disorder or a 
first-degree family member with a schizophrenia spectrum illness. Brief intermittent psychotic 
symptoms state consists of one or more positive psychotic symptoms that exceed the threshold 
for psychosis, but a frequency too brief to meet criteria for a schizophrenia spectrum illness. 
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Conversion. Conversion to psychotic disorder is defined as at least one of the five 
attenuated positive symptoms reaching a psychotic level of intensity (rated 6) for a frequency of 
≥ 1 h/day for 4 days/week in the past month, or that symptoms seriously impacted functioning 
(e.g. severely disorganized or dangerous to self/others) (McGlashan et al., 2010). Symptoms 
were assessed with the Scale of Prodromal Symptoms (SOPS), which is comprised of 19 items in 
four symptom domains: positive, negative, general, and disorganized. In the present sample, 29 
participants in the CHR group (14 males, 15 females) and 5 participants in the HSC group (2 
males, 3 females) converted to psychosis.  
Substance use. Substance use was rated using a well-established rating scale, the Alcohol 
and Drug Use Scale (AUS/DUS) (Drake, Mueser, McHugo, 1996). The AUS/DUS is a 12-item 
scale that assesses severity of substance use within the past month. Each item is rated on a 5-
point scale (1-5) where a rating of 1 is “abstinent,” 2 is “use without impairment,” 3 is “abuse,” 4 
is “dependence,” and 5 is “severe dependence.” Ratings between 3 and 5 are indicative of 
behaviors associated with DSM-IV diagnoses of substance abuse and dependence. There is one 
severity rating at baseline for each of the following substances: alcohol, marijuana, cocaine, 
opiates, PCP, amphetamines, MDMA/ecstasy, GHB, glue/other volatiles, hallucinogens, and 
other substances. 
Mood symptomatology. Calgary Depression Scale for Schizophrenia (CDSS: Addington, 
Addington, & Maticka-Tyndale, 1993) is a semi-structured interview used to measure depressive 
symptomatology within the past week. The CDSS has been validated in CHR individuals 
(Addington, Shah, Liu, & Addington, 2014), and distinguishes depressive symptoms from 
negative symptoms better than other measures (Addington, Addington, & Maticka-Tyndale, 
1994; Collins, Remington, Coulter, & Birkett, 1996). The CDSS is a 9-item scale that assesses 
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severity of depressive symptoms during the past week. Each item is rated on a 4-point scale (0-3) 
with low ratings indicating the absence of a symptom and high ratings indicating a severe 
symptom. Full administration of the CDSS generates a total score (range: 0-27). 
The Young Mania Rating Scale (YMRS, Young, Biggs, Ziegler, & Meyer, 1978) is a 
semi-structured interview to measure mania symptomatology within the past month. The YMRS 
is an 11-item scale with 7 items measuring the following: elevated mood, increased motor 
activity, sexual interest, sleep, language—thought disorder, appearance, and insight. Such items 
are rated on a 5-point scale (0-4) where a rating of 0 is “absent” and a rating of 4 is “severe”. The 
YMRS also includes 4 items measuring the following on a 9-point scale (0-8; absent-severe): 
irritability, speech (rate and amount), disruptive-aggressive behavior, and content. YMRS 
administration results in a total score (range: 0-60).   
Internalized stigma. Personal Beliefs about Experiences Questionnaire (PBEQ; Morrison 
et al., 2013; Pyle et al., 2015) is a revised version of the Personal Beliefs about Illness 
Questionnaire (PBIQ; Birchwood, Mason, MacMillan, & Healy, 1993). The PBIQ evidenced 
strong reliability (Birchwood et al., 1993). As the PBIQ was developed for individuals with 
established schizophrenia, items were removed that were unrelated to the CHR population. Items 
were as follows, “I will always need to be cared for by professional staff”, “People like me must 
be controlled by psychiatric services”, and “If I am going to relapse, there is nothing I can do 
about it”.  
The PBEQ is a 13-item measure assessing internalized stigma and cognitive appraisals 
about CHR experiences. It has been validated for use in the CHR population (Pyle et al., 2015). 
Each item is a statement concerning stereotypical beliefs about psychosis (e.g., “My experiences 
may mean that I should be kept away from others”). The respondent must rate the degree to 
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which this statement is true of them on a 4-point scale (1-4); lower ratings indicate strong 
disagreement and higher ratings indicate strong agreement. PBEQ administration results in a 
total score (range: 13-52). Three items were summed to create the “control over illness” 
subscale, consistent with previous work (Birchwood, Jackson, Brunet, Holden, & Barton, 2012; 
Stowkowy et al., 2015).  
 Social Cognition Measures 
Theory of mind (ToM). ToM was assessed with the “Reading the Mind in the Eyes” task 
(Eyes Task: Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001), a multiple choice task 
requiring the participant to infer mental/emotional states from 36 cropped photos of pairs of 
eyes. Participants are instructed to select one of four words that best describe what the person is 
thinking or feeling based on their eyes. Participants are given a practice item to ensure 
understanding of the task. They are provided with standardized definitions of word choices at 
their request. The number of correctly identified faces indexes performance (range: 0-36). The 
Eyes Task was selected for its frequent usage in schizophrenia spectrum disorders (Pinkham et 
al., 2013).  
Emotion perception (EP). Face Emotion Identification Task (FEIT) and the Face 
Emotion Discrimination Task (FEDT) were used to measure EP in facial expressions (Kerr & 
Neale, 1993). Both tasks are comprised of black and white facial photographs presented using a 
DVD. The FEIT contains 19 photographs depicting six basic emotions (happy, sad, afraid, angry, 
surprised, and ashamed). Faces are presented for 15 seconds each with 10 seconds of blank 
screen separating each presentation. FEIT performance is indexed as the total number of correct 
facial emotion identifications (range: 0-19). The FEDT is comprised of 30 pairs of faces, 
instructing the participant to judge whether the two faces are displaying the same or different 
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emotions. Emotions are consistent with those depicted in the FEIT. Pairs of faces are presented 
for 15 seconds each with 15 seconds of blank screen separating each presentation. FEDT 
performance is indexed as the total number of correct discriminations (range: 0-30). 
The Affective Prosody Task (AP) (Edwards, Pattison, Jackson, & Wales, 2001) was used 
to assess EP in voices. AP stimuli are comprised of audio recordings of three professional actors 
speaking four simple sentences ("they must stay here", “we must go there”, “she will drive fast”, 
and “he will come soon”) in voices expressing fear, sadness, anger, surprise, and neutral (no 
emotion). Each actor is associated with three practice items and 20 test items, resulting in 60 
total items (range: 0-60) indexing performance. Responses are coded as correct or incorrect and 
correct responses are summed for a total score. The reliability coefficient (Cronbach’s Alpha) for 
AP is .85 (Edwards et al., 2001). 
All social cognitive tests, ranges, and normative data from healthy control groups are 
provided in Table 1. 
 Functioning measures 
 Social functioning. Social functioning was measured using the Social Functioning Scale 
(SFS; Birchwood et al., 1990). The SFS is a self-report measure with well-established 
psychometric properties in individuals with schizophrenia spectrum illnesses (Birchwood et al., 
1990) and is commonly used in CHR samples. The SFS is a self-report questionnaire that 
generates seven subscale scores in addition to a total score: withdrawal/social engagement, 
interpersonal communication, independence performance, independence competence, recreation, 
prosocial behaviors, and employment/occupational. The respondent must rate the degree to 
which this statement is true of them on a 4-point scale (0-3); lower ratings indicate lower 
functioning (range: 0-223). 
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 The SFS has been criticized for overlap with measures of occupational functioning and 
thus not being a pure measure of social functioning (Cornblatt et al., 2007). Pijnenborg et al. 
(2009) performed a principal components analysis of SFS subscales and found that the SFS 
employment item is a separable subscale. As the present study is interested more in social 
functioning rather than a combined measure of social and role functioning, the subscale 
measuring occupational functioning will be removed from the SFS total score (range: 0-213). 
 Role functioning. The Heinrichs-Carpenter Quality of Life Scales (QLS) measures role 
functioning (Heinrichs, Hanlon, & Carpenter, 1984). The QLS is a clinician rated, semi-
structured interview. The QLS is frequently used in schizophrenia spectrum illnesses, and has 
evidenced strong convergent validity in associations with performance-based assessments of 
functional capacity (Sabbag et al., 2011). The QLS is comprised of four items, each rated on a 7-
point (0-6) scale. Lower ratings indicate low quality of life and higher ratings indicate greater 
quality of life. Full administration of the QLS results in the following 4 domain scores: 
accomplishment, occupational functioning, underemployment, and satisfaction with occupational 
functioning. Total score is computed by summing accomplishment, occupational functioning, 
and underemployment items (range: 0-18). The satisfaction with occupational functioning item is 
only administered if the occupational functioning item is rated at least 3.  
 Premorbid functioning. Premorbid functioning was assessed using the Premorbid 
Adjustment Scale (PAS; Cannon-Spoor et al., 1982), which is a semi-structured interview that 
measures premorbid functioning retrospectively. Participants are rated on social (i.e., 
sociability/withdrawal and peer relationships) and academic maladjustment across 
developmental phases. The PAS has well established predictive and convergent validity (Brill et 
al., 2008), and is frequently used to measure premorbid functioning in schizophrenia spectrum 
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illnesses. PAS is comprised of 26 items, each rated on a 7-point scale (0-6), with lower ratings 
indicating low maladjustment and higher ratings indicating high maladjustment.  
The PAS measures four domains in addition to a total score: sociability/withdrawal, peer 
relationships, functional ability apart from nuclear family, and ability to function at a 
developmentally appropriate socio-sexual level. Four developmental stages are rated, childhood 
(up to age 11), early adolescence (age 12-15), late adolescence (16-18), and adulthood (age 19 
and older). Subscale scores are computed by dividing the obtained score by the total possible 
score for that developmental stage. Thus, subscale scores are as numbers ranging from 0.0 to 1.0, 
with lower numbers representing more “adaptive” levels of functioning. Given the association of 
early and late adolescence social maladjustment and subsequent conversion, the present study 
will use an overall social maladjustment score composed of an average of early and late 
adolescent social maladjustment scores (Tarbox et al., 2013; Tarbox et al., 2014).  
General scores were not used, in accordance with administration and scoring procedures 
outlined by van Mastrigt and Addington (2002). Adult PAS ratings were not included in the 
present analyses given the sample’s baseline age (mean: 19.63, SD: 4.29) and lack of utility for 
44.6% of the total participants (i.e., individuals under age 19). 
Neurocognitive measures 
 Neurocognitive measures were selected on the basis of demonstrated reliability, validity, 
absence of ceiling and floor effects in the CHR population, ability to discriminate individuals 
with schizophrenia from healthy controls, and appropriateness for administration in individuals 
as young as 14 years of age. For the present study, a subset of neurocognitive indicators were 
selected from a larger battery (e.g., Barbato et al., 2013a; Barbato et al., 2013b). Tasks were 
selected from domains that have evidenced sensitivity to subsequent conversion to psychosis, 
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such as verbal memory, verbal fluency, processing speed, attention, and executive functioning 
(Cornblatt et al., 2015; Frommann et al., 2010; Riecher-Rössler et al., 2009; Seidman et al., 
2010). Neurocognitive tests, indices, ranges, and normative data from healthy control groups are 
provided in Table 1. 
This study was developed and data collected prior to the Measurement and Treatment 
Research to Improve Cognition in Schizophrenia initiative and associated battery, which is 
currently the gold standard neurocognitive assessment in individuals with schizophrenia 
spectrum illnesses (Green et al., 2004). However, half of the presently included indices are in the 
consensus battery (i.e., Trail Making Test A and B, Continuous Performance Test—Identical 
Pairs).  
Intelligence (IQ) was measured using the Wechsler Adult Intelligence Test or the 
Wechsler Intelligence Scale for Children-III, depending on age of the participant. Age-scaled IQ 
is computed from the following subtests: block design, arithmetic, digit symbol/coding, 
vocabulary, and information (Wechsler, 1974; Wechsler, 1981) 
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Data Analyses 
 
 Data analyses were performed using Mplus version 7 (Muthén & Muthén, 2012) and 
SPSS version 23. Statistical significance will be defined as p < .05 unless otherwise specified.  
Latent Profile Analysis 
Latent profile analysis (LPA) is useful in situations where a group may be better 
represented by distinct subgroups or categories of individuals. LPA is used to identify subtypes 
of related cases, also known as latent classes. Classes are latent because they are not directly 
observable and must be identified based on a pattern of observable indicators (i.e., previously 
referred to as predictive indicators). Use of LPA is appropriate when it is hypothesized that 
internally homogenous latent subgroups are present, each subgroup responding similarly to a set 
of indicators, but not similarly to individuals in other subgroups. Thus, LPA assumes local 
independence of indicators, which can be defined as independence of indicators outside of an 
individual’s latent class. Subgroups are heterogeneous within the larger sample such that 
response patterns to indicators can be distinguished from one another based on subgroup 
membership (Collins & Lanza, 2010).  
The broad objective of LPA is to capture meaningful response patterns within the data, or 
to meaningfully cluster individuals based on their responses on indicators of interest. The 
number of distinct response patterns determines the number of classes. Thus, LPA is an analogue 
of factor analysis; where factor analysis often investigates the latent structure of variables, LPA 
and other finite mixture models investigate the latent structure of cases. Similar to factor 
analysis, just as the researcher must assign labels to the factors based on factor structure, the 
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researcher must assign labels to the latent classes that are generated. Similar to interpreting factor 
loadings to assign indices to factors, an individual’s mean posterior probability of class 
membership must be examined to determine subgroup membership. 
Conceptual underpinnings of latent variable models are such that the latent variable (i.e., 
risk subgroup membership) is what affects indicators (e.g., suspiciousness, unusual thought 
content, neurocognitive impairment, etc.). The causal flow is from the latent variable to the 
indicator variable. In the present study, subgroup membership associated with higher risk of 
transition would affect increased symptom ratings. Further, there are two influences that 
determine an individual’s observed response on the indicator variable, the individual’s latent 
class membership (i.e., subgroup membership) and error. As error variance is decreased, there is 
a greater likelihood that the individual’s observed responses on indicators are reflections of the 
individual’s latent class. To this end, it is vital to use indices with strong psychometric 
properties. An advantage of LPA is that, like other latent variable models, LPA estimates and 
adjusts for measurement error (Collins & Lanza, 2010). 
There are several advantages of using LPA over other statistical approaches in the present 
study. LPA is able to separate groups even if there is overlap. LPA modeling readily includes 
cases with missing data. LPA can be used with indicators of different types (e.g., continuous, 
ordinal, categorical), and covariates can be entered into the LPA model to further characterize 
classes (Dayton & Macready, 1988). Covariates are a key interpretational tool to assist in the 
investigation of differences between latent classes. Lastly, mixture models (e.g., LPA) do not 
assume normality of data, linearity, or homogeneity of variances, but rather assumes that there 
exist k (clusters) normal distributions within the population. This provides distinct advantages 
over logistic regression models, which requires assumptions are met of linearity with 
  47 
transformation, normality of residuals, and homoscedasticity, all of which may be violated if 
latent subgroups exist among CHR individuals (Collins & Lanza, 2010). 
Aims & Hypotheses 
Hypothesis 1: It was hypothesized that LPA methods will reveal homogenous 
subgroups from the psychopathologically heterogeneous sample. To evaluate the first 
hypothesis, an exploratory LPA was conducted with the full sample (CHR and HSC individuals; 
n = 271). The combined sample was used because 5 individuals converted within the HSC group 
(14.7% of total converters), thus there may be latent subgroups of interest among HSC 
individuals. If internally homogenous latent subgroups truly exist among the CHR subgroup, 
they would be identified in applying LPA to the combined sample. The following continuous 
indicators were entered in the LPA model: SOPS individual symptoms, CDSS total symptoms, 
and all neurocognitive indicators included in Table 1.  
In the present study, the number of classes were not estimated a priori, but were 
ascertained from a combination of model fit statistics and interpretability. The model of best fit 
(i.e., number of classes) was determined from examinations of all of the following criteria: (1) 
Akaike’s Information Criteria (AIC; Lin & Dayton, 1997), Bayesian Information Criteria (BIC; 
Schwarz, 1978), and sample size adjusted BIC (ssa BIC; Sclove, 1987) (lower values are 
indicative of the model of best fit), (2) Bootstrapped Likelihood ratio tests (BLRT) were used to 
compare n and n -1 number of classes (McLachlan & Peel, 2000), (3) Mean estimated average 
posterior probabilities of individual cases belonging to each class, (4) Entropy indices, or 
probability statistics between 0 and 1 (0 = low classification utility; 1 = higher classification 
utility). Both (3) and (4) are considered indices of model classification utility and rely on the 
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estimated posterior probabilities. Substantive interpretability and parsimony of the models were 
also considered in model selection. 
Hypothesis 2: It was hypothesized that the subgroup associated with the highest risk 
of conversion will include: high attenuated psychotic symptoms (e.g., unusual thought 
content, suspiciousness, social anhedonia, and occupational functioning), and 
neurocognitive impairment (e.g., processing speed, verbal memory, verbal fluency, and 
working memory). To test hypothesis 2, after latent classes were determined using the 
procedures outlined above, the risk of conversion associated with each subgroup was computed. 
First, risk was computed as the % of converters in each subgroup out of the total subgroup n, and 
transition rate was compared across classes using χ2 tests of significance. Second, risk was 
computed using Kaplan-Meier survival analysis to investigate rates of conversion over the full 
five years of assessment (Kaplan & Meier, 1958). To account for attrition and in accordance with 
statistical procedures as outlined by Kaplan and Meier (1958), study dropouts were counted as 
“survivors” (nonconverters) and were deleted from the number “at risk” at the following time 
point. The results of the Kaplan-Meier curve were also interpreted. 
Hypothesis 3: It was hypothesized that negative symptoms (i.e., SOPS negative 
symptom subscale) and neurocognitive indicators (e.g., verbal memory and processing 
speed) will be the most influential in the LPA modeling process. To test hypothesis 3 and 
assess the importance of indicators in the LPA process, subgroups were compared on all 
indicators using univariate analyses of variance (ANOVAs) and effect sizes (r2). When 
appropriate, pairwise comparisons were conducted using Bonferroni correction for multiple 
comparisons. Further, LPA generated an indicator profile depicting all included indices (e.g., 
SOPS symptoms, CDSS total symptoms, neurocognitive scores) using estimated sample means 
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from each subgroup. This indicator profile was visually inspected to discern which indicators 
were influential in the LPA modeling process (Collins & Lanza, 2010).  
Hypothesis 4: It was hypothesized that the subgroup associated with the highest risk 
of conversion would be further characterized by impairment in ToM, decreased control 
over experiences, recent cannabis and alcohol abuse, poor premorbid functioning, and 
racial ethnic minority status. To test hypothesis 4, univariate analyses of variance (ANOVAs), 
independent samples t tests, and chi-square tests of significance were conducted to compare the 
subgroups on the following continuous/categorical covariates: ToM score, facial EP total score, 
AP score, PBEQ total score, PBEQ “control over experiences” subscale total, AUS/DUS item 
scores, PAS social and academic maladjustment subscale scores for developmental phase (i.e., 
child, early adolescent, late adolescent) and combined early/late adolescent social maladjustment 
score, and self-reported race/ethnicity and other demographic information (e.g., age, sex, 
parental education). When appropriate, pairwise comparisons were conducted using Bonferroni 
correction for multiple comparisons. Z-square cell comparison tests with Bonferroni correction 
were used to probe significant omnibus chi-square tests and determine which groups were 
significantly different from one another (Goodman, 1969; Sharpe, 2015).  
Hypothesis 5: It was hypothesized that subgroups would evidence significant 
between group differences across time points on functionality, and that functional level will 
change over time within each subgroup. To test hypothesis 5, longitudinal functioning was 
investigated in each of the subgroups generated in the LPA model. Prior to this, a test of attrition 
bias was conducted as this sample evidences significant attrition. Independent samples t tests 
and/or chi-square tests were conducted to compare individuals with and without usable data (e.g., 
having at least one additional follow up visit) on the following indices: gender, age, parental 
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education, SOPS positive symptom subscale, total social functioning (SFS) score (without 
employment item), and total role functioning (QLS) score. Generalized linear mixed models 
(GLMM) for repeated measures analyses were then used to examine change over time (baseline, 
6 months, 12 months, 18 months, 24 months) and group differences for ratings on the functional 
indices. Least Square Means (LS-Means) were obtained from the mixed models with Hochberg’s 
correction for multiple comparisons. Hochberg’s correction was selected for its conservative 
estimates in GLMM (Hothorn, Bretz, & Westfall, 2008). 
Exploratory Analyses  
Exploratory Aim 1: Evaluate the covariates that best predicted subgroup 
membership. Exploratory aim 1 was assessed using multinomial regression analyses. Class 
membership was the dependent variable, and all LPA covariates evidencing significant group 
differences (hypothesis 5) were entered as independent variables and regressed on class 
membership status. As this was an empirically driven aim rather than hypothesis driven, forward 
stepwise model selection was used to enter predictors into the regression model to assess which 
indicators explained the most variance in subgroup membership. Wald Chi-square tests of 
significance were examined to determine which indicators are significantly contributing to 
subgroup membership. Odds ratios and associated modeled probability table were examined to 
interpret results. 
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Results 
 
Primary Analyses 
 Latent profile analysis (LPA) 
 LPA model selection. LPA analyses were conducted using Mplus version 7 with Mixture 
Add-On (Muthén & Muthén, 2012). Raw scores were used in accordance with recommendations 
of Muthén (2001), as variable standardization results in analyses using a correlation matrix, 
which are only adequate for scale-free data only (Muthén & Muthén, 2000). Indicators in the 
current model are, on the other hand, not scale-free; and rather than seeking to explain a 
correlation matrix, LPA seeks to explain the covariance matrix of observed indicators with latent 
variables (Muthén & Muthén, 2000). Neurocognitive variables were not age standardized prior to 
entry in the LPA model due to non-normal distributions and scarcity of adequate age adjusted 
norms. Thus, age was investigated as an inactive descriptive covariate in LPA analyses.  
 Though a greater number of potential indicators were available for inclusion in the model 
(e.g., premorbid functioning), only a subset of the initially proposed indicators were selected. 
Balance must be achieved among sample size, number of indicators, and parameters to be 
estimated for sufficient statistical power (Tein, Coxe, & Cham, 2013). The addition of redundant 
or unnecessary indicators to the LPA model, specifically in a model with a small sample size 
(i.e., n < 1000), often results in poor and inaccurate model fit. As such, indicators were limited to 
those theorized to be most closely influenced by latent subgroup membership (sub-psychotic 
symptomatology, neurocognitive performance, depressive symptoms). Neurocognitive indicators 
were selected from domains with well-established relationships with conversion to psychosis, 
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such as executive functioning, attention, (e.g., Riecher-Rössler et al., 2009), verbal memory and 
fluency (Cornblatt et al., 2015; Seidman et al., 2010), and processing speed (Frommann et al., 
2010). Twenty-six total indicators were included in the model, including all SOPS symptoms 
measuring prodromal symptoms (19), CDSS total score measuring depressive symptoms (1), and 
neurocognitive scores (6).  
 Table 2 provides the fit indices from the LPA. Five models were estimated specifying 
between one and five latent classes. The sixth model would not estimate due to too few 
individuals in class 6 (n = 8). The AIC, BIC, and ssa BIC values decreased with each successive 
class addition and thus did not readily discriminate a model of best fit. The BLRT value 
remained significant (p < .0001) with each class addition to the model. Entropy values remained 
high for each class model (k = 2-5), ranging from 0.88-0.93. Using only available information 
criteria and likelihood ratio tests, the 5-class test would be selected. However, accepting the 
model associated with the lowest AIC, BIC, ssa BIC and BLRT values does not prioritize model 
interpretability and parsimony. Further, the large number of indicators in the present model may 
artificially result in a large k class model when a more parsimonious model may be better fitting 
and more clinically meaningful (Tein et al., 2013).  
 An alternative interpretation of information criteria (e.g., AIC, BIC, ssa BIC) and log 
likelihood value is to plot the values in graphical form (e.g., scree plot) (Nylund, Asparouhov, & 
Muthen, 2006). Model fit indices are plotted against the number of latent classes and examined 
for the “leveling off” point of the curve. Identifying the model associated with a subsequent 
decrease in slope may provide a model that balances model fit statistics and parsimony (Nylund, 
Asparouhov, & Muthen, 2006). Models identified through scree plot consensus are then 
examined for theoretical interpretability and meaningful class separation across indicators. 
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  Figure 1 provides scree plots of AIC, BIC, ssa BIC, and log likelihood value associated 
with each class model. The leveling off point of the curves occurred at three classes in each of 
the scree plots, indicating that significant improvements in model fit are not gained with further 
class additions to the model (i.e., k > 3). The three-class solution indicated high quality of 
classification, with an adequate entropy score of 0.884 and mean posterior probabilities of class 
membership ranging from 93.9% to 95.6%. Table 3 summarizes the latent class membership 
based on estimated posterior probabilities. Indicators evidenced meaningful class separation. 
Interpretability of the model will be discussed in the subsequent sections.  
 Individuals were assigned to classes as indicated by the highest posterior probability 
value as such: class 1 (mild symptom cluster) was the largest class with 124 individuals, 
followed by class 2 (positive-depressive cluster) with 106 individuals, and class 3 (negative-
neurocognitive cluster) with 41 individuals.  
Classes and risk probability. The overall transition rate in the full combined sample at 
two years was 12.5% (converters n = 34, combined sample N = 271). Conversion rate to 
psychosis significantly differed across groups in the overall model (χ2 (2, N = 271) = 16.08, p < 
.001). Pairwise comparisons indicated that conversion to psychosis was more likely in 
individuals in class 3 (negative-neurocognitive; transition risk 29.3%, n = 12 converters) than 
class 1 (mild; transition risk 5.6%, n = 7 converters) at the p < .05 level. There were no 
significant differences in other pairwise comparisons between class 2 (positive-depressive; 
transition risk 14.2%, n = 15 converters) and class 1 (mild) or class 3 (negative-neurocognitive). 
Kaplan-Meier survival curve. Thirty-four of the 271 individuals experienced 
conversion to psychosis with a mean (SD) time to conversion of 359.3 (319.2) days since 
baseline (range: 27-1185 days). The nonconverters (n = 237) were followed up for a mean (SD) 
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of 441.1 (461.9) days since baseline. There were no significant differences regarding the age of 
conversion to psychosis among class 1 (M1 = 20.01, SD = 2.73), class 2 (M2 = 21.46, SD = 4.92), 
and class 3 (M3 = 19.96, SD = 4.48) (F(2,31) = 0.47, p = 0.629). 
The overall model evidenced a significant Breslow (Generalized Wilcoxon) statistic, 
indicating significant differences early in the survival curves (χ2 (1, N = 271) = 10.97, p < .001). 
The overall model also evidenced a significant Tarone-Ware test, indicating significant 
differences in the intermediate area of the survival curves (χ2 (2, N = 271) = 11.45, p < .001). 
Lastly, the overall Log Rank (Mantel-Cox) comparisons were also statistically significant (χ2 (2, 
N = 271) = 11.99, p < .001), indicating that the survival curves were significantly different 
during the later time period of the study.  
Figure 2 depicts the results of the Kaplan-Meier survival analysis, plotting the percentage 
of individuals in each class who did not experience conversion to psychosis (nonconverters) at 
each assessment during the 5-year follow up period. Individuals who do not experience 
conversion to psychosis contribute to the survival model until they are no longer available for 
observation, at which point they are censored.  
Areas of increased slope may be interpreted as increased rates of conversion during that 
time period. Class 3 (negative-neurocognitive) and 2 (positive-depressive) evidenced high rates 
of transition during the early follow up period (6 months, approximately 10% drop in survival). 
After 6 months, Class 2 evidenced deceleration in transition rate compared to class 3 (negative-
neurocognitive). Class 1 (mild) reached the 10% drop in the survival curve until 18 months, 
indicating that baseline mild symptoms and minimal neurocognitive impairment are associated 
with a subsequent transition to psychosis. Class 1 (mild) evidences an overall lower transition 
rate, with a notable increase at 36 months. Classes are well separated in transition rate in the 
  55 
intermediate and later areas of the curve. However, given the high rate of attrition in the present 
sample, the implications of these findings are tentative as the sample size is smaller in the final 
three years of study and dropouts that may have transitioned to psychosis were censored.  
Characteristics of the three-class solution. Table 4 shows the results from the latent 
profile analysis (i.e., estimated means and standard errors). Figures 3 and 4 show the latent 
profile plots of the estimated means for each class. To assess the importance of indicators in the 
latent profile process, we estimated the explained variance using univariate ANOVAs, the results 
of which are also provided in Table 4. Pairwise comparisons were conducted using Bonferroni 
correction for multiple comparisons. ANOVA results indicated that all included indicators were 
influential in the clustering process, with the exception of SOPS symptoms grandiose ideas (P3) 
and bizarre thinking (D2).  
Examinations of the SOPS latent profile plot and pairwise comparisons indicated that 
class 1 (mild) evidenced the lowest prodromal symptom scores across SOPS symptoms and 
CDSS total score. Class 1 (mild) largely evidenced SOPS estimated means around a rating of 1, 
which connotes a symptom that occurs rarely (e.g., less than monthly) and is of questionable 
presence. Class 1 (mild) evidenced slightly higher ratings (around 2) in symptoms measuring 
unusual thought content, suspiciousness, and perceptual abnormalities, which suggests such 
positive symptoms occur monthly and are of mild intensity. Lastly, class 1 (mild) evidenced a 
level of depression comparable to healthy control sample norms (normative mean: 2.6, SD: 2.7; 
Müller et al., 2005) 
The estimated means associated with class 2 (positive-depressive) were remarkable for 
having significantly greater ratings on suspiciousness/persecutory ideas (P2) than classes 1 
(mild) and 3 (negative-neurocognitive). Class 2 (positive-depressive) evidenced significantly 
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greater ratings than class 1 (mild) on unusual thought content and perceptual abnormalities, but 
not class 3 (negative-neurocognitive). While class 2 (positive-depressive) was not statistically 
significant from class 3 (negative-neurocognitive) in other positive symptom pairwise 
comparisons, inspection of the latent profile plot indicated that class 2 (positive-depressive) 
tended to have greater ratings (P1-P4) than classes 1 (mild) and 3 (negative-neurocognitive). 
Class 2 (positive-depressive) was also noted to have significantly higher ratings of depression, as 
they had a moderate SOPS dysphoric mood rating and higher CDSS total scores. Individuals in 
class 2 (positive-depressive) also evidenced significant sleep disturbance compared to other 
classes. Class 2 (positive-depressive) had negative symptom ratings at or less than a rating of 2 
(mild), with the exception of occupational functioning, which neared a rating of 3 (indicating 
moderate impairment).  
Class 3 (negative-neurocognitive) membership was associated with the highest ratings in 
a majority of symptoms in the negative symptom domain (e.g., ratings between 2-4), and to a 
lesser degree, was associated with the disorganized symptom domain. This was confirmed 
statistically through pairwise comparisons, as class 3 (negative-neurocognitive) showed 
significantly greater ratings than classes 1 (mild) and 2 (positive-depressive) on symptoms of 
social anhedonia (N1), expression of emotion (N3), ideational richness (N5), and occupational 
functioning (N6). Classes 2 and 3 evidenced ratings of comparable magnitude in avolition (N2) 
and decreased experience of emotions (N4). Classes 2 (positive-depressive) and 3 (negative-
neurocognitive), on the other hand, were not well distinguished from each other in ratings of 
disorganized communication (P5), motor disturbances (G3), and impaired tolerance to normal 
stress (G4). 
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Regarding neurocognitive performance, classes 1 (mild) and 2 (positive-depressive) 
performed comparably across indices. On Trails B, class 2 (positive-depressive) evidenced 
increased performance compared to class 1 (mild), though this finding was no longer significant 
after correction for multiple comparisons (p = .054). Class 3 (negative-neurocognitive) 
evidenced significant impairment compared to classes 1 (mild) and 2 (positive-depressive) across 
all measured neurocognitive indices (p < .05). As the neurocognitive test scores were not 
corrected for age before entry into the LPA model, comparisons among classes on 
neurocognitive indices were also run as analyses of covariance (ANCOVAs) with age entered as 
a covariate. All overall models remained significant (p < .001) and pairwise comparisons using 
Bonferroni correction for multiple comparisons remained significant (p < .05), indicating that 
classes significantly differed on neurocognitive performance when accounting for variance 
related to age. 
Characterizing the three-class solution with covariates. To further characterize 
associated features of classes, we conducted ANOVAs and chi-square tests of significance to 
compare classes on a variety of different covariates. The results of demographic characteristics 
are provided in Table 5 and clinical covariates are provided in Table 6. 
Demographic characteristics. There were significant differences in age and clinic 
location between the three classes. Pairwise comparisons indicated that individuals in class 3 
(negative-neurocognitive) were significantly younger than individuals in class 2 (positive-
depressive). Individuals from Yale were more likely to be classified in class 3 (negative-
neurocognitive) and less likely to be classified in class 2 (positive-depressive). Conversely, 
individuals from UNC were more likely to be classified in class 2 (positive-depressive) and less 
likely to be classified in class 3 (negative-neurocognitive).  
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Given site effects, comparisons among classes on indicators (SOPS symptoms, CDSS 
total score, neurocognitive indices) were also run as analyses of covariance (ANCOVAs) with 
site entered as a covariate. Overall models that had evidenced significance (e.g., Table 4) 
remained statistically significant (p < .01) and all pairwise comparisons using Bonferroni 
correction for multiple comparisons remained significant (p<.05), indicating that classes 
significantly differed on indicators when accounting for variance related to site. 
Classes did not evidence significant differences in racial/ethnic composition, 
identification as Hispanic/Latino, or parental education. Racial/ethnic background was recoded 
from a variable with five levels to a dichotomous “white” and “other race” variable. Classes 
again did not evidence significant differences using recoded variables. 
Clinical characteristics. There were significant differences among classes at baseline 
regarding risk group characterization (HSC vs. CHR). CHR individuals were significantly more 
likely to be categorized in class 2 (positive-depressive) than individuals in class 1 (mild). 
Conversely, HSC individuals were more likely to be categorized in class 1 (mild) than class 2 
(positive-depressive).  
Classes evidenced significant overall models concerning ratings of internalized stigma 
(PBEQ) total score, the “control over experiences” subscale (PBEQ), and total mania score 
(YMRS). Classes 2 (positive-depressive) and 3 (negative-neurocognitive) were characterized by 
significantly greater YMRS total scores and indices of internalized stigma at baseline compared 
to class 1 (mild). There were no significant differences between classes 2 and 3. 
Regarding baseline alcohol and drug use, overall ANOVA models were statistically 
significant for MDMA/ecstasy and “other” substance usage. Pairwise comparisons for 
MDMA/ecstasy usage did not reach significance; however, class 2 (positive-depressive) was 
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significantly more likely to engage in “other” substance use compared to class 1 (mild). The 
following substances (n = frequency) were reported in class 2 (positive-depressive): ketamine (n 
= 3), sleeping pills (n = 2), morning glory seeds (n = 1), salvia (n = 1), and nitrous oxide (n = 1).  
Functioning. Classes evidenced significant overall group differences across all subscale 
ratings of premorbid adjustment (PAS). From childhood through early adolescence (i.e., up to 
age 15), individuals categorized into class 3 (negative-neurocognitive) showed both significant 
social and academic maladjustment scores compared to classes 1 (mild) and 2 (positive-
depressive). Classes 1 (mild) and 2 (positive-depressive) showed comparable levels of 
impairment during this time period. Regarding late adolescence social maladjustment ratings 
(i.e., age 16-18), class 3 (negative-neurocognitive) continued to perform at the most impaired 
level with respect to classes 1 (mild) and 2 (positive-depressive). However, class 2 (positive-
depressive) evidenced significant social maladjustment compared to class 1 (mild), thus first 
began to evidence a pattern of premorbid maladjustment. The averaged early and late 
adolescence social maladjustment score showed a pattern consistent with late adolescence social 
maladjustment. This pattern was similar regarding academic maladjustment in late adolescence, 
as class 3 (negative-neurocognitive) evidenced the greatest impairment; however, the pairwise 
comparison between class 2 (positive-depressive) and class 1 (mild) only approached 
significance (p = .059). 
Regarding baseline role functioning, class 3 (negative-neurocognitive) evidenced 
significantly impaired QLS ratings measuring occupational functioning, accomplishment, and 
underemployment compared to classes 1 (mild) and 2 (negative). Class 2 (positive-depressive) 
evidenced functional impairment when compared to class 1 (mild) on accomplishment and 
underemployment and total QLS score. Role satisfaction comparisons were conducted between 
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classes for individuals who were rated at least 3 on the occupational functioning item (86.7% of 
class 1, 75.8% of class 2, 57.9% of Class 3). Class 1 (mild) reported significantly greater role 
satisfaction than class 2 (positive-depressive). The pairwise comparison between class 1 (mild) 
and class 3 (negative-neurocognitive) only approached significance (p = .053), possibly due to 
the decreased sample size of class 3 (n = 22) and associated low power. 
Social cognition. Classes evidenced significant overall models measuring group 
differences in performance on the Eyes Task, FEIT, and AP. The overall model for the FEDT 
approached statistical significance (p = .053). Pairwise comparisons indicated that class 3 
(negative-neurocognitive) evidenced significant social cognitive impairment compared to classes 
1 (mild) and 2 (positive-depressive) across measures. Class 1 (mild) and 2 (positive-depressive) 
evidenced no significant differences. Thus, class 3 (negative-neurocognitive) evidenced 
impairment in both theory of mind and emotion perception. 
As social cognitive performance tends to be associated with age, comparisons among 
classes on social cognitive indices were also run as analyses of covariance (ANCOVAs) with age 
as a covariate. Overall models for Eyes Task, FEIT, and Affective Prosody Task remained 
significant (p < .001) and pairwise comparisons corrected for multiple comparisons remained 
significant (p < .05), indicating that classes evidenced significant differences in social cognitive 
performance when accounting for variance related to age. 
Social cognitive performance also tends to be associated with neurocognitive ability, thus 
comparisons among classes on social cognitive indices were also conducted as ANCOVAs with 
age-scaled IQ score included as a covariate. Overall models for Eyes Task and Affective Prosody 
task remained significant (p < .05); however, FEDT was no longer statistically significant. 
Pairwise comparisons for Affective Prosody remained significant (p < .05). The Eyes Task 
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contrast between class 2 (positive-depressive) and 3 (negative-neurocognitive) was no longer 
statistically significant. Results indicate that significant group differences in facial emotion 
perception performance and ToM may be partially accounted for by neurocognitive ability; 
however, not affective prosody.  
Intelligence. Classes were also compared with respect to age-scaled IQ Score. Classes 
were significantly different, with specific impairment in class 3 (negative-neurocognitive) 
compared to classes 1 (mild) and 2 (positive-depressive). Classes 1 (mild) and 2 (positive-
depressive) evidenced comparable performance. Results are consistent with those from 
neurocognitive indicators. 
Functional trajectory of subgroups. Two hundred and forty-six total individuals (139 
males and 107 females) completed the SFS at baseline. Of those 246 participants, 144 completed 
the 6-month follow up, 114 completed the 12-month follow up, 84 completed the 18-month 
follow up, and 59 completed the 24-month follow up. Reasons for dropout are provided in the 
Appendix B. Given the significant dropout rate in the present sample, a test of attrition bias was 
conducted to compare individuals with usable longitudinal data (e.g., data from at least baseline 
and one other time point; “non-dropouts”, n = 173) and those without usable longitudinal data 
(e.g., individuals with baseline data only; “dropouts”, n = 73). Chi-square tests were conducted 
to compare dropouts and non-dropouts on sex and parental education. Independent samples t-
tests were used to compare groups on age, SOPS positive symptom subscale, total social 
functioning (SFS) score (i.e., without occupational subscale), and total role functioning (QLS) 
score (items 1-3). There was a significant difference in QLS total score for non-dropouts (Mnon-
dropouts = 13.11, SD = 4.72) and dropouts (Mdropouts = 11.34, SD = 5.16), such that dropouts 
evidenced significantly impaired role functioning as compared to non-dropouts (t(244) = -2.61, p 
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= .01). There were no other significant differences between groups. Therefore, the subsequent 
functional trajectory analyses will include only the SFS total score with occupational functioning 
subscale removed, given significant differences in role functioning between dropouts and non-
dropouts.   
Table 7 provides the mean estimates, standard error, and n for each class at each time 
point. Table 8 shows the results from the generalized linear mixed model (GLMM) for repeated 
measures analysis between groups across time points. At both baseline and the 6-month follow 
up assessments, class 1 (mild) evidenced significantly higher SFS total score than classes 2 
(positive-depressive) and 3 (negative-neurocognitive). There were no significant group 
differences between the 12-18 month follow up assessments. At 24-month follow up, both 
classes 1 (mild) and 2 (positive-depressive) evidenced significantly higher SFS total scores than 
class 3 (negative-neurocognitive).  
Table 9 shows the results from the GLMM for repeated measures analysis within groups 
to assess change over time. Class 2 (positive-depressive) evidenced significant improvement in 
SFS score between baseline and 24-month follow up. Improvement between baseline and 12-18 
months neared significance after correction for multiple comparisons (p = .053 - .082). Classes 1 
(mild) and 3 (negative-neurocognitive) evidenced no significant changes in social functioning 
over time. Figure 5 plots estimated means for each class over time to visually represent the data. 
Exploratory Analyses 
Contribution of covariates to group membership. To investigate the covariates that 
best predicted class membership, a multinomial logistic regression (MLR) analysis was 
conducted with class membership as the dependent variable. To reduce the number of 
independent variables in the model, covariates were selected that evidenced significant group 
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differences in prior analyses, and total scores were used when appropriate: YMRS total score, 
MDMA/ecstasy use, other substance use, PAS subscales (child and early adolescent subscales 
only), QLS Total score, Eyes Task total score, FEIT total score, and AP total score. Cognitive 
variables (e.g., IQ score) were not included in the MLR model, as this would be redundant with 
the neurocognitive indicators entered in the initial LPA model. Forward stepwise selection was 
used, as this method is suitable for use with a large number of independent variables. Of note, 
MLR utilizes listwise deletion and missing data was not imputed (n = 69), as this is an 
exploratory analysis. Thus, the sample size is smaller than the original sample (class 1, n = 96, 
77.4%; class 2, n = 73, 68.9%; class 3, n = 33, 80.5%). 
The overall MLR model was significant, indicating that the current model predicts class 
membership significantly better than the null model (χ²(14) = 103.43, p < .00001). The best 
model based on forward stepwise model selection included the following covariates: PAS child 
academic maladjustment score (χ²(2) = 7.80, p = .020), PAS early adolescent social 
maladjustment score (χ²(2) = 6.30, p = .043), QLS Total Score (χ²(2) = 27.68, p < .001), Eyes 
Task total score (χ(2) = 14.46, p = .001), FEIT total score (χ²(2) = 5.32, p = .070), and Affective 
Prosody total score (χ²(2) = 7.13, p = .028). Thus, of the covariates that evidenced significant 
group differences, indices measuring premorbid maladjustment, role functioning, theory of mind, 
and emotion perception were most influential in the LPA clustering process. Indices measuring 
mania and substance use were not selected by the model and did not further the model’s ability 
to predict class membership. 
Table 10 provides parameter estimates for classes 2 (positive-depressive) and 3 
(negative-neurocognitive) as compared to the reference group, class 1 (mild). The estimated 
multinomial logistic regression coefficient (B) is provided for the intercept and each predictor 
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covariate variable selected by the forward stepwise function. The logistic coefficient (B) can be 
interpreted such that, for one unit change in the independent variable, the logit of the outcome 
associated with the reference group (class 1) is expected to change by the parameter estimate B. 
For example, in class 2 (positive-depressive), the B value associated with the PAS early 
adolescent social maladjustment score is 1.46; this means that if an individual’s PAS score was 
to increase by one unit (i.e., indicating greater premorbid maladjustment), the multinomial log-
odds of being classified in class 2 (positive-depressive) instead of class 1 (mild) would be 
expected to increase by 1.46 units while holding all other variables in the model constant. 
Positive B values indicated the probability of belonging to the reference group (i.e., class 1) 
decreases, and negative B values indicated increased probability of belonging to the reference 
group (class 1). The closer a logistic coefficient is to zero, the less influence the independent 
variable had in predicting the logit.  
Odds ratio values represent the logistic regression odds associated with each predictor 
variable. Odds ratios greater than one indicate that as the independent variable increases, the 
individual is x (OR value) times more likely to fall in the comparison group (class 2 or 3) than 
the referent group (class 1). For example, in class 2 (positive-depressive), the odds ratio value 
associated with the PAS early adolescent social maladjustment score is 4.31; if two individuals 
had a one point difference in early adolescent social maladjustment, the individual with the 
higher score has a relative risk of falling in class 2 (positive-depressive) that is 4.31 times more 
likely than class 1 (mild) when holding all other variables in the model constant.  
To enhance clinical application of the patterns associated with this model, a modeled 
probability table was computed with MLR results and odds ratios. Table 11 shows the six 
clinical characteristic indices selected in the forward stepwise model to explain class 
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membership in the MLR model and associated probabilities of falling into each class depending 
on a hypothetical index score. Index scores are described as “average,” “low,” and “high,” such 
that they are the grand mean of that variable, one standard deviation below, and one standard 
deviation above, respectively. Table 11 can be interpreted such that if an individual performs one 
standard deviation below the grand mean in total role functioning score (QLS), holding all other 
indices at their respective grand mean, they are 35.48% likely to fall in class 1 (mild), 52.27% 
likely to fall in class 2 (positive-depressive), and 12.25% likely to fall in class 3 (negative-
neurocognitive). Changes in magnitude within each class for a group of index scores may also be 
interpreted. For example, as the total role functioning score increased from low to high, the 
probability of being classified in class 1 (mild) increased substantially, and class 2 (positive-
depressive) and 3 (negative-neurocognitive) decreased substantially. Comparatively, little 
magnitude in change in probability of class membership occurred in classes 1 (mild) and 2 
(positive-depressive) as affective prosody score increases from low to high. Average values were 
the same across all comparisons because they were at the grand mean of that index and all other 
variables were held constant at their grand mean. Of note, probability was also driven by sample 
size of each class, thus class 3 (n = 33, 16.3% of sample) had lower modeled probabilities 
overall.  
Individuals had a ~50% likelihood or greater of falling into class 1 (mild) with high 
childhood academic maladjustment, low early adolescent social maladjustment, high role 
functioning, high theory of mind, high face emotion recognition, and high affective prosody 
ability. Individuals had a ~50% likelihood or greater of falling into class 2 (positive-depressive) 
with low childhood academic maladjustment, high early adolescent social maladjustment, low 
role functioning, and low face emotion recognition. Individuals had a ~10% likelihood or greater 
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of falling into class 3 (negative-neurocognitive) with low role functioning, low theory of mind, 
and low affective prosody ability. 
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Discussion 
The central aim of the present study was to investigate whether a sample of 
symptomatically heterogeneous CHR and HSC individuals was comprised of different 
subgroups, each associated with different rates of transition to psychosis and symptom 
constellations. Our hypotheses were supported, as meaningful subgroups emerged from LPA 
analyses. A three-class model was of best fit and evidenced adequate separation across 
indicators. Our hypothesis was further supported such that each class was associated with 
different patterns of symptomatology. Class 1 (mild) had few symptoms rated above a “mild”, 
with the exception of one positive symptom (e.g., unusual thought content), and the lowest 
transition rate (5.6%). Class 2 (positive-depressive) had the greatest positive symptoms of the 
subgroups, mild or lesser negative symptoms, moderate depression and sleep disturbance, and a 
greater transition rate (14.2%). Though classes 1 (mild) and 2 (positive-depressive) differed with 
respect to SOPS symptomatology, they exhibited comparable neurocognitive performance, 
performing at or near the level of healthy controls according to established norms. Class 3 
(negative-neurocognitive), however, had the greatest negative symptoms overall, with positive 
and depressive symptoms lower than class 2 (positive-depressive). Class 3 (negative-
neurocognitive) was found to have the most severe neurocognitive deficits across indices, and 
was associated with the greatest transition rate (29.3%).  
The present study found that classes were best distinguished by separation in negative 
symptoms (e.g., social anhedonia, occupational functioning, decreased expression of emotion, 
and decreased ideational richness) and general symptoms (e.g., sleep disturbance, dysphoric 
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mood). This finding is consistent with prior latent variable work, where classes were clearly 
separated by differences in negative symptoms and behavioral change variables (e.g., social 
isolation, impaired role functioning) (Valmaggia et al., 2013). Further consistent with prior work, 
classes exhibiting the greatest baseline negative symptoms and behavioral change ratings had the 
highest risk of transition to psychosis (i.e., Class 3) (Valmaggia et al., 2013). These findings are 
consistent with the growing literature establishing an association between high baseline negative 
symptoms and subsequent conversion to a psychotic disorder (Alderman et al., 2015; Demjaha et 
al., 2012; Miller et al., 2003; Lencz et al., 2004; Nelson et al., 2013; Piskulic et al., 2012; 
Riecher-Rossler et al., 2009; Velthorst et al., 2009; Yung et al., 2003; Yung et al., 2005; Yung et 
al., 2010; Yung & McGorry 1996b). Class 3 (negative-neurocognitive) was also characterized by 
significantly impaired neurocognition, performing at least one standard deviation worse than 
class 1 (mild) and class 2 (positive-depressive) across domains.  
While the present study replicated several past findings, it also found a novel latent 
profile structure, distinct from Valmaggia et al., (2013), that included neurocognitive variables as 
indicators in the LPA model. The inclusion of neurocognition in the model may have elicited the 
emergence of class 3 (negative-neurocognitive), a novel subgroup with the highest transition risk 
that is characterized by negative symptoms and comorbid neurocognitive impairment (i.e., 
instead of overall high symptom subgroup). To elucidate the possible clinical implications and 
progression of class 3 (negative-neurocognitive), it is useful to briefly review attempts to parse 
heterogeneity in established psychoses. 
From Bleuler’s (1911) first observation of the heterogeneity in the “Group of 
Schizophrenias,” it has been argued that schizophrenia is an umbrella term for several distinct 
diseases within schizophrenia (Moskowitz & Heim, 2011). Efforts to parse phenomenologically 
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distinct subgroups resulted in the identification of the deficit and nondeficit subtypes of 
schizophrenia (Carpenter et al., 1988). Deficit schizophrenia is a well-defined subgroup of 
schizophrenia characterized by a chronic course of illness, prominent and persistent negative 
symptoms, and neurocognitive and social cognitive impairment (Kirkpatrick, Buchanan, Ross, & 
Carpenter, 2001). The deficit subtype has substantial empirical support and clinical utility, with a 
unique etiology, neurobiology, course/chronicity, and pathological profile (e.g., Ahmed et al., 
2014; Kirkpatrick, Buchanan, Ross, & Carpenter, 2001; Voineskos et al., 2013). Current 
literature indicates that approximately 15-30% of patients meet deficit criteria, and that it is 
present from the first episode (e.g., Kirkpatrick, Fenton, Carpenter, & Marder, 2006). Further, 
there is evidence that individuals with persistent negative symptoms (i.e., a key feature of deficit 
subtype) have a distinct deficit in gray matter volume compared to individuals without persistent 
negative symptoms (e.g., Buchanan et al., 1993; Lei et al., 2015), as well as white matter 
abnormalities (Hovington et al., 2015). Deficit schizophrenia, therefore, has been argued to be 
the most valid taxon amidst a heterogeneous group of psychoses (Ahmed et al., 2014).  
The discovery of deficit schizophrenia was considered a paradigm shift within 
schizophrenia research and the field of psychiatry more broadly (Carpenter, Arango, Buchanan, 
& Kirkpatrick, 1999), and aspects of this theory have received comparatively scant attention in 
CHR individuals. The closest analogue of deficit subtype in CHR individuals is Cornblatt and 
colleagues (2003) proposed “CASIS” model, a two-part explanation of psychosis development. 
The first dimension of the CASIS model posits that a base biological neurodevelopmental 
vulnerability to psychosis (e.g., genetic heritability, pre- and perinatal viral infection) underlies 
the prodrome and affects neurocognitive deficits and functional disability, irrespective of 
conversion to psychosis. Four domains define the CASIS model, including neurocognitive 
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deficits, affective disturbance (e.g., depression), negative symptoms of social isolation (i.e., 
social dysfunction), and school failure (i.e., occupational dysfunction). The second dimension of 
CASIS regards positive psychotic threshold symptoms, which develop in some individuals who 
show signs of CASIS, but not all (Cornblatt et al., 2003). While conclusions are tentative, 
individuals meeting CASIS criteria may be further divided into two putative subgroups based on 
the present results: (1) class 2 (positive-depressive) experiencing attenuated positive symptoms, 
moderate affective symptoms, and intact neurocognition, and (2) class 3 (negative-
neurocognitive) experiencing moderate negative symptoms, low affective symptoms, and 
profound neurocognitive deficits (functional deficits to be discussed in subsequent sections). 
Further examination of class 3’s (negative-neurocognitive) phenotypic presentation 
shows it may be an early manifestation of the deficit subtype: prominent negative symptoms, 
significantly impaired neurocognition and social cognition, and poor premorbid functioning. 
Research related to prominent, early onset negative symptoms further supports a possible CHR 
deficit subtype classification. In a sample of CHR individuals, negative symptoms had an 
average age of onset of 11.7 years and a significantly longer duration than positive symptoms 
(Demmin, Carrion, Auther, McLaughlin, & Cornblatt, 2013).  
Despite the utility of the deficit schizophrenia subtype, this has not been added to the 
DSM-5, because there is currently no valid typification of the remaining heterogeneous 
nondeficit subtypes (Braff, Ryan, Rissling, & Carpenter, 2013). It follows that characterizing 
nondeficit subgroup(s) in the present combined CHR and HSC sample proves difficult. Classes 
were not as clearly separated across the positive symptom subscale, consistent with Valmaggia et 
al.’s (2013) findings. However, class 2 (positive-depressive) had significantly higher paranoia 
and unusual thought content, thus, the present study is distinct from prior latent variable models 
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in that class 2 (positive-depressive) evidences a distinct symptom constellation. Class 2’s 
(positive-depressive) symptom constellation may be best illustrated through SOPS descriptive 
anchors associated with mean estimate symptom ratings. They had moderate paranoia (e.g., may 
be mistrustful with SOPS interviewer, feel like others are saying negative things about them), 
mild negative symptoms such as social anhedonia (e.g., slightly socially awkward and passively 
goes along with social activities) and moderate occupational dysfunction (e.g., difficulty 
finishing work tasks or drop in GPA), and mild to moderate general symptoms (e.g., daytime 
fatigue from mild insomnia, feeling the “blues” have settled in) (McGlashan et al., 2010). Class 2 
(positive-depressive) can be further characterized by the highest CDSS scores in the current 
sample (i.e., increased depressive symptoms); approximately one standard deviation higher than 
the mean in CHR individuals without mood disorders (Addington, Shah, Liu, & Addington, 
2014). CDSS total approached a rating of 6, which is a cutoff associated with major depression 
in individuals with schizophrenia spectrum illness (Müller et al., 2005). Class 2 (positive-
depressive) evidenced intact neurocognition compared to healthy control normed data (Table 1). 
As such, class 2 (positive-depressive) evidences largely non-specific distress, with a mild 
emphasis in positive and affective symptoms compared to other classes.  
Despite LPA efforts, it is likely that there is limited ability to parse heterogeneity within 
class 2 (positive-depressive), such that it is comprised of individuals with a broad range of 
symptomatology that may subsequently transition to mood disorders, anxiety disorders, 
personality disorders, later onset psychotic disorders, eating disorders, or other diagnoses. Thus, 
class 2 (positive-depressive) may be at risk for a broad range of psychopathology. However, a 
recent study incorporating the present sample found that emergent psychosis was significantly 
more likely than any nonpsychotic disorder (Webb et al., 2015). Given that the inclusion criteria 
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of this study was one follow up visit (e.g., 6 months), it may be that CHR criteria are sensitive to 
emergent psychosis for some, but that timing was not sufficient to capture the emergence of 
nonpsychotic disorders, which take years to manifest past adolescence/early adulthood (e.g., 
average age range of study was 15.7-19.6 across groups) (Webb et al., 2015). For example, the 
median age of onset for mood disorders is 30 (Kessler et al., 2005). This is in line with McGorry 
et al.’s (2006) proposed clinical staging model of prodromal disorders, which posits that non-
specific distress crystallizes over time into discrete categorical syndromes. Thus, efforts at 
identifying homogenous subgroups at this time may be difficult due to the ephemeral nature of 
distress and symptomatology through adolescence, and the dynamic patterns of psychopathology 
that manifest through the transition to adulthood (McGorry, Purcell, Goldstone, Amminger, 
2011) (see clinical staging model figure in Appendix C). While the clinical staging model 
continues to exist largely as a theoretical framework instead of a concrete clinical application, it 
emphasizes the needs for early intervention irrespective of conversion risk, and urges care 
providers to tailor interventions to presenting symptomatology (McGorry & van Os, 2013).  
Rate of Transition to Psychosis 
Our hypotheses regarding clinical features associated with the subgroup at the highest 
risk of transition were partially supported, as class 3 (negative-neurocognitive) had the highest 
conversion rate (29% transition rate). This is consistent with the broader regression literature and 
prior latent variable work, where baseline neurocognition and negative symptoms have been 
associated with subsequent conversion (e.g., Addington & Heinssen, 2012; Valmaggia et al., 
2013).  
Inconsistent with our hypotheses, the highest risk class (Class 3 – negative-
neurocognitive) was not also characterized by significantly greater positive symptoms (e.g., 
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unusual thought content, suspiciousness). Class 2 (positive-depressive) was associated with the 
highest positive symptoms, intact neurocognition, and a lower rate of transition (14.9%). The 
absence of clear associations between positive symptoms and conversion is inconsistent with the 
literature, which indicates that higher baseline positive symptoms are associated with subsequent 
conversion, and that attenuated positive symptoms are the final phase of the prodrome before 
conversion to psychosis (e.g., Addington & Heinssen, 2012; Cornblatt et al., 2003). However, as 
previously discussed, regression literature may not be relevant unless it is conducted within 
putative subgroups, as significant associations would be muted with heterogeneity.  
The decreased rate of transition associated with class 2 (positive-depressive) may be 
related to the subgroup’s intact neurocognitive performance, as they performed comparably to 
non-psychiatric control participants. It is possible that neurocognitive ability is protective against 
reaching full threshold psychosis, as positive symptoms are less likely to reach a delusional level 
if one has the ability to correct erroneous beliefs and consider alternative explanations for 
anomalous experiences (i.e., metacognition) (Beck et al., 2004). Adequate neurocognitive ability 
is a pre-requisite for the capacity to undertake more complex abilities such as metacognition and 
cognitive insight in chronic psychoses (Lysaker et al., 2010). Further, lack of cognitive insight is 
associated with the development and maintenance of positive symptoms of full psychotic 
disorders (Garety et al., 2001). Class 2’s (positive-depressive) intact neurocognition may have 
facilitated cognitive flexibility and metacognitive functioning, thus enabling the group to be 
more skeptical of suspicious or unusual thoughts. Further research is required to clarify the 
relationship amongst neurocognition, cognitive insight, and delusional development in CHR 
individuals. 
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Overall, the present study did not clearly enhance the risk prediction model beyond CHR 
criteria, as the highest risk group is associated with a 29.1% conversion rate, which is nearly 
identical to the overall rate of conversion in help seeking individuals who meet CHR criteria 
(29%, Fusar-Poli et al., 2012). However, there is a relatively low rate of conversion in the 
present study (17% of CHR group), thus a subgroup with a transition rate of 29.1% may still be a 
meaningful enhancement in specificity. The present study is associated with a lower conversion 
rate in the highest risk group (Class 3 – negative-neurocognitive), approximately 12% lower than 
Valmaggia et al.’s (2013) severe symptom group. Differential rates of conversion may be related 
to methodological differences in subthreshold psychotic symptom scale selection (e.g., SIPS vs. 
CAARMS); for example, the CAARMS does not include a specific item measuring 
paranoia/suspiciousness, which was the SOPS item that class 2 (positive-depressive) evidenced 
significantly higher ratings on. Such difference may have resulted in a different class structure 
and associated rates of transition compared to Valmaggia et al. (2013).  
The Kaplan-Meier survival curves revealed significant group differences. Class 3 
(negative-neurocognitive) evidenced the most rapid rate of transition of the three groups. At 24 
months, the rate of conversion in classes 1 (mild) and 2 (positive-depressive) largely stalled, 
while individuals in class 3 (negative-neurocognitive) continued to evidence conversion. Classes 
were generally well separated in survival rates, indicating that classes have distinct patterns of 
conversion over time, and thus may be phenomenologically distinct. This is a novel finding, as 
Valmaggia et al. (2013) found comparable survival curves amidst subgroups with the exception 
of the severe symptom cluster. Further work would be required to replicate the current class 
structure and assess survival rate over time to better characterize each subgroup.  
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Further Characterizing Subgroups with Covariates 
Our hypothesis that the subgroup associated with the highest risk of conversion would be 
further characterized by impairment in ToM, decreased control over experiences (internalized 
stigma), recent cannabis and alcohol abuse, and racial/ethnic minority status was partially 
supported.  
Class 3 (negative-neurocognitive) had significantly lower social cognitive performance 
across domains compared to other classes, consistent with the proposed conceptualization of 
class 3 (negative-neurocognitive) as a CHR analogue of the deficit subgroup. Meta-analytic 
findings indicate that individuals with deficit schizophrenia have significant social cognitive 
impairments compared to nondeficit schizophrenia individuals (ES = 0.56, Cohen et al., 2007). 
Such findings provide further evidence of the possibility that there may exist a 
pathophysiologically distinct deficit subgroup within the prodome. In contrast, classes 1 (mild) 
and 2 (positive-depressive) performed comparably to healthy controls on measures of ToM and 
facial emotion perception according to established norms from age matched healthy controls 
participants.  
Results from a recent meta-analysis evaluating social cognition in individuals at CHR 
found medium effect sizes for EP (d = 0.47) and ToM impairment (d = 0.44) (van Donkersgoed 
et al., 2015). Thus, one would expect class 2 (positive-depressive) to have EP and ToM deficits, 
given that this class was largely comprised of CHR individuals (74.5%). Further, results 
comparing CHR and HSC individuals from the current sample found no significant differences 
in EP or ToM performance (Addington et al., 2008; Healey et al., 2013). Thus, it is possible that 
deficit subgroups within such help seeking populations are responsible for social cognitive 
deficits in heterogeneous CHR samples.  
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There was no differentiation between classes 2 (positive-depressive) and 3 (negative-
neurocognitive) in scores pertaining to internalized stigma (PBEQ) and perceived control over 
experiences subscale (PBEQ). Both classes reported negative beliefs concerning their clinical 
symptoms and specific absence of control, as they agreed with statements such as, “My 
experiences frighten me,” and “I find it difficult to cope.” Prior research has found that negative 
beliefs are closely associated with negative symptoms, depression, and suspiciousness, which 
characterize both classes (Pyle et al., 214; Stowkowy et al., 2015). Recent work regarding 
negative personal beliefs in individuals with more established serious mental illness found that 
such negative beliefs may be further divided into three distinct factors: external shame, internal 
shame/defectiveness, and general negative expectations/appraisals (Taylor et al., 2015). 
Subgroups may be differentially experiencing such negative belief factors, which may have 
different implications for treatment and amelioration of social dysfunction. The literature on 
internalized stigma related to clinical experiences is in an early phase, and specific associations 
with symptom clusters may emerge as future work is undertaken. 
Hypotheses regarding cannabis and alcohol abuse in the highest risk class were not 
supported. It is possible that this lack of an effect is related to restricted range of substance use in 
the present sample, as scores evidenced high endorsement of abstinence and substance use 
without impairment. The only notable finding was related to “other” drug use, where class 2 
(positive-depressive) had significantly higher use than class 1 (mild). This is in line with some 
work that indicates individuals with more prominent positive symptoms tend to use more 
substances (Dominguez, Saka, Lieb, Wittchen, & van Os,, 2010). While substance use may not 
demonstrate a consistent relationship with transition to psychosis, substance usage in adolescents 
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may underlie the transdiagnostic risk factor of emotion regulation deficits and thus warrant 
further exploration in help seeking individuals (Shadur and Lejuez, 2015).  
The overall model for symptoms of mania (YMRS) was significantly different and was 
driven by higher ratings in classes 2 (positive-depressive) and 3 (negative-neurocognitive). 
While the YMRS has not undergone psychometric validation in CHR individuals, inspection of 
means and standard deviations from the current study indicates that classes evidenced scores 
comparable to other outpatient CHR individuals (total score < 4; e.g., Hui et al., 2013). Scores 
less than four are considered to be in the non-clinical range and not reaching a “mild” threshold 
of mania (Lukasiewicz et al., 2013). In a sample with more severe psychopathology, inpatient 
adolescents at CHR and non-CHR did not show significant differences in YMRS total score, 
indicating that in more severe manifestations of the prodrome, mania symptoms are not unique to 
CHR individuals (Gerstenberg et al., 2015). Further, baseline mania has not been shown to be 
predictive of subsequent conversion to psychotic spectrum illnesses, including affective 
psychoses (e.g., Amminger et al., 2006, Cornblatt et al., 2012). Taken together, YMRS symptom 
scores appear to be a non-specific indicator of distress in CHR individuals, rather than a key 
feature of the psychosis prodrome.  
We did not find that the group at highest risk of transition to psychosis was comprised of 
a greater number of ethnic and racial minorities, as we had hypothesized. It is possible that racial 
ethnic minority status identification is not the variable most proximal to psychosis risk, but, 
rather, indices of perceived discrimination and salience of racial identity may be more relevant 
(Kessler, Mickelson, & Williams, 1999). Perceived discrimination spans across various facets of 
multicultural identity, including skin color, race/ethnicity, socioeconomic status, gender, age, 
appearance, disability, religion, and sexual orientation, among others. Indeed, recent research has 
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indicated that CHR individuals report significantly higher perceived discrimination than healthy 
controls, and that this is unrelated to attenuated psychotic symptoms (e.g., paranoia) (Saleem et 
al., 2014). Future research may investigate the role of perceived discrimination in predicting 
subsequent conversion and functional impairment in CHR subgroups. 
Regarding demographic characteristics, classes evidenced significant differences 
regarding age. The age differences were driven by class 2 (positive-depressive) being 
significantly older than class 3 (negative-neurocognitive). Given longitudinal findings indicating 
negative symptom onset predates positive symptom onset, it would follow that the youngest 
group may be characterized by predominant negative symptoms (Häfner, Maurer, & an der 
Heiden, 2013). In a large longitudinal prospective cohort study that used a dimensional approach 
towards symptoms (i.e., clustering negative/disorganized symptoms and positive symptoms 
separately), negative/disorganized symptoms predicted the occurrence of positive symptoms over 
time (Demjaha et al., 2012). Thus, negative/disorganized symptoms may serve as a precursor to 
attenuated positive symptoms (Dominguez et al., 2010). Further longitudinal research is required 
to establish the pattern of symptom development, and potential differential pattern amongst 
putative CHR subgroups. 
Classes also had significant differences in clinic of origin, as individuals from UNC-CH 
were significantly more likely to be classified in class 1 (mild) and 2 (positive-depressive) than 
class 3 (negative-neurocognitive). Individuals from Yale were significantly more likely to be 
classified in class 3 (negative-neurocognitive) than classes 1 (mild) and 2 (positive-depressive). 
ANOVAs across LPA indicators were repeated as ANCOVAs controlling for the effect of site, 
and results were unchanged. Further, each of the three clinics used standardized inclusion 
criteria, screening and assessment measures, and recruitment methods, and raters evidenced 
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significant agreement in routine assessment reliability checks (kappa = 0.90). It is possible that 
site differences between classes may be used descriptively to understand possible regional 
differences in symptomatology, course, and chronicity. While on the surface, Yale and UNC-CH 
are situated in college towns of comparable square mileage; they differ in population density, 
climate, and crime rate, among several other factors. Given the relationship between population 
density and risk for psychosis (see review: Heinz, Deserno, & Reininghaus, 2013), it is not 
surprising that 90% of the sample that comprises highest transition risk class 3 (negative-
neurocognitive) comes from the two sites with the highest population densities (Yale, Toronto).  
Class 3 (negative-neurocognitive) exhibited the greatest premorbid academic/social and 
baseline role dysfunction across items and subscales, with scores comparable to individuals with 
established schizophrenia (Cannon-Spoor et al., 1982). During childhood, classes 1 (mild) and 2 
(positive-depressive) both evidenced premorbid functioning comparable to healthy control norms 
(Cannon-Spoor et al., 1982). Class 2 (positive-depressive) evidenced functional deterioration 
over time, and was statistically comparable to class 3’s (negative-neurocognitive) dysfunction in 
late adolescent academic maladjustment score, and evidenced significant impairment with 
respect to class 1 (mild) in late adolescent social maladjustment, role functioning 
accomplishment/unemployment, and role functioning total score. Taken together, class 2 
(positive-depressive) had significant social and role impairment, but to a lesser degree and with 
later onset than class 3 (negative-neurocognitive). Of note, a recent cluster analysis of premorbid 
adjustment scores using the CHR group from the present sample found three unique trajectories 
of premorbid functioning (stable-intermediate, stable-good, and deteriorating). Each cluster 
evidenced significant differences in negative/disorganized symptoms but not positive symptoms, 
providing further evidence of there being an association between negative symptoms and 
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premorbid dysfunction in CHR individuals (Lyngberg et al., 2015). Such findings are consistent 
with the literature in established schizophrenia, which have detected an association between poor 
premorbid functioning and negative symptoms (e.g., Schmael et al., 2007), and continue to fit 
our conceptualization of class 3 (negative-neurocognitive) as a CHR deficit subtype with marked 
dysfunction both before and during the prodrome.  
Consistent with our hypothesis, the class at the greatest risk of transition to psychosis 
(class 3 – negative-neurocognitive) had the greatest baseline role dysfunction compared to 
classes 1 (mild) and 2 (positive-depressive). It is of use to contextualize level of role function 
with respect to healthy individuals and those with psychotic spectrum illnesses. Class 3’s 
(negative-neurocognitive) total QLS score is comparable to that of a sample of individuals with 
established, multiple episode psychosis (Addington et al., 2008). Class 1 (mild) approached the 
mean total score from a non-psychiatric control sample (Addington et al., 2008). Class 2 
(positive-depressive) evidenced significantly impaired functioning compared to class 1 (mild), 
with a total score comparable to the general CHR group. Regarding dissatisfaction with one’s 
role functioning, pairwise comparisons indicated that class 2 (positive-depressive) had the 
greatest dissatisfaction compared to class 1 (mild), while the class 3 (negative-neurocognitive) 
and class 1 (mild) comparison only approached statistical significance. Taken together, such 
findings are consistent with the view of class 3 (negative-neurocognitive) as a CHR deficit 
subgroup with milder depression and lacking in cognitive insight (i.e., related to neurocognitive 
dysfunction), resulting in less role dissatisfaction despite their having the lowest role functioning 
overall (Lysaker et al., 2010).  
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Social Functioning Trajectory Within and Across Classes 
Hypotheses related to between group differences in social functioning trajectory were 
partially supported, as class 1 (mild) evidenced the highest level of social functioning, and more 
symptomatic classes 2 (positive-depressive) and 3 (negative-neurocognitive) evidenced the 
lowest level of social functioning. Current literature investigating predictors of social 
dysfunction in CHR individuals indicates that those with prominent negative symptoms, 
disorganized symptoms, neurocognitive impairment, and social cognitive impairment have 
significantly worse social functioning over time (e.g., Carrion et al., 2011; Cotter et al., 2014; 
Meyer et al., 2014; Milev, Ho, Arndt, & Andreasen, 2005; Pijnenborg et al., 2009). Further, a 
growing body of research indicates that negative symptoms are responsible for a significant 
amount of the variance in social functioning, above and beyond neurocognition (Corcoran et al., 
2011; Schlosser et al., 2015). Thus, the clinical features of class 3 (negative-neurocognitive) 
have an established association with subsequent social dysfunction in the literature.  
Given the growing literature in support of the relationship between negative symptoms 
and social functioning, we would expect class 3 (negative-neurocognitive) to perform 
significantly worse than class 2 (positive-depressive); however, both classes had a similar level 
of impairment. Of particular interest, class 2 (positive-depressive) evidenced low social 
functioning despite having intact neurocognition and social cognition, two areas that have been 
considered key determinants of functional ability in established schizophrenia (meta-analysis: 
Fett et al., 2011). It is possible that class 2 (positive-depressive) experienced a constellation of 
mild-moderate clinical symptoms that dynamically interacted with one another to create social 
dysfunction, rather than individual symptoms of severe intensity that explained significant 
variance in functioning in a regression model (van Os, 2013). Additionally, some research 
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indicates that depressive symptoms predict social functioning (and role functioning) above and 
beyond variance explained through negative symptoms (Corcoran et al., 2011; Fulford et al., 
2013). Class 2 (positive-depressive) evidenced significantly higher depressive symptomatology 
than other classes, which may be interacting with other baseline psychopathology (e.g., 
suspiciousness) to result in isolation and social dysfunction.  
Hypotheses related to significant changes over time within each class were only partially 
supported. Classes 1 (mild) and 3 (negative-neurocognitive) evidenced no significant changes 
over time, which may indicate that they have stable-intermediate and poor social functioning, 
respectively. Class 2 (positive-depressive) evidenced a mild degree of SFS improvement over 
time. Relatedly, class 2 (positive-depressive) evidenced significantly higher SFS scores than 
class 3 (negative-neurocognitive) at the 24-month follow up assessment. While such longitudinal 
results must be interpreted with caution given the significant rate of attrition, they are consistent 
with the extant literature and our present conceptualization of classes 2 (positive-depressive) and 
3 (negative-neurocognitive). Class 3 (negative-neurocognitive) would be expected to evidence a 
more chronic course with persistent functional deficits, in line with the neurodevelopmental 
hypothesis and CHR-DS presentation. Conversely, symptom heterogeneity of class 2 (positive-
depressive) may be associated with ephemeral symptom severity associated with improved 
functioning.   
Contribution of Covariates to Group Membership  
An additional exploratory aim was to evaluate the set of indices that best predicted 
subgroup membership. MLR analyses indicated that functional and social cognitive indices were 
the best predictors; whereas, covariates measuring substance use and mania were not selected by 
the forward stepwise model and did not significantly predict subgroup membership. And, 
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considering both the MLR statistics and modeled probabilities of class assignment based on 
selected covariates, baseline role functioning appeared to best predict class membership. Results 
were consistent with the findings of Valmaggia et al. (2013), who found that occupational status 
and overall functioning score best predicted class membership. Regarding premorbid 
functioning, a notable finding is that as childhood academic maladjustment increased from low 
to high, the likelihood of falling in class 2 (positive-depressive) decreased while the likelihood of 
falling in class 1 (mild) increased. Thus, class 2 (positive-depressive) had intact role functioning 
in childhood.  
Interestingly, performance on social cognitive indices significantly contributed to the 
model predicting class membership, though the strength of this relationship was not as strong as 
functional indicators. Significant findings appeared to be driven by class 3 (negative-
neurocognitive), as low scores in theory of mind and affective prosody were associated with a 
higher likelihood of falling into class 3 (negative-neurocognitive), holding all other variables 
constant. 
Limitations and Strengths 
 As latent variable analyses are influenced by subtle differences in the sample, the present 
latent structure must be replicated several times to ensure the validity of the putative CHR deficit 
subgroup. The total sample size did not allow for cross-validation, which would enhance 
confidence regarding the validity of this taxon. Further, it is possible that the model may have 
better parsed the heterogeneity within class 2 (positive-depressive) with an increased sample size 
(Tein et al., 2013). Further, the overall reliability of LPA results may be affected by low 
prevalence rate of some symptoms (e.g., P5 disorganized communication) in the current sample, 
which has been influential in predicting conversion and functionality in prior work (e.g., 
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Corcoran et al., 2011; Dominguez et al., 2010). Thus, the present findings are tentative until they 
are replicated using a larger sample. 
 As previously mentioned, the present class structure revealed significant differences with 
regard to assessment site. We elected not to include site as a covariate in the LPA model, 
because in the case of employing a single covariate, the log-linear model is identical whether site 
is treated as an active covariate or as an additional indicator variable (Clogg, 1981; Hagenaars, 
1990; Magidson & Vermunt, 2001). Given that sites did not have significant differences in rates 
of converters (i.e., latent variable of “risk of psychosis” did not directly affect indicator site 
membership), we instead elected to use site as an inactive descriptive covariate. Further, 
significant differences between indicator variables remained when controlling for the effect of 
site, indicating true variance in symptomatology drove the clustering method. However, we 
cannot exclude the possibility that there may be differences between the three sites that may have 
affected differences in symptomatology. 
  Lastly, the present sample had a high rate of attrition. Given such attrition, it is likely 
that the longitudinal GLMM was underpowered. However, power analyses were not conducted 
so this cannot be statistically confirmed. It should be noted that attrition is a common limitation 
of CHR studies, as it is generally difficult to keep adolescents in longitudinal studies of 
significant duration. There is evidence that difficulties recontacting members of adolescent and 
young adult psychiatric cohorts is associated with increased presence of disorder at follow-up 
(Allott, Chanen, & Yuen, 2006). This is consistent with our findings that dropouts had poorer 
role functioning than non-dropouts. Thus, it is likely that the present study was not able to 
capture the most severely ill individuals over time.  
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Strengths of the present study included the ecological validity in the application of the 
latent profile analyses to the combined sample. Thus, analyses represent subgroups of self-
presenting, help seeking individuals that are realistically seen at CHR clinics. Our use of 
neurocognitive performance scores as indicators in the latent variable model is novel and the first 
study to date to utilize such. This is a key strength, as cognitive deficits are a core feature of the 
CHR state. The current study is further strengthened by inclusion of a broad range of covariates 
(e.g., functioning, social cognition, internalized stigma) to characterize the subgroups at baseline 
and over time, which extends previous latent variable models.  
Future Directions and Treatment Implications 
 Detecting putative subgroups within heterogeneous populations improves research, 
assessment, and encourages more tailored treatment to emergent symptom clusters. The current 
study was able to parse heterogeneity within the present sample of help seeking individuals. The 
present results provide further evidence that there may exist a subgroup characterized by 
predominant negative symptoms, neurocognitive and social cognitive impairment, and poor 
premorbid and baseline functioning. If such a subgroup exists in the broader population and is 
replicated in future latent mixture models, CHR subgroups may be considered distinct 
subclinical entities with different symptom courses and associated treatments. 
 As class 3 (negative-neurocognitive) was characterized by early functional deterioration, 
(i.e., during childhood) it may be advantageous to begin risk assessment and treatment at an 
earlier age to offset persistent dysfunction. Neurocognitive deficits and negative symptoms tend 
to appear earliest in the course of CHR, and the latter are often difficult to identify (Kahn & 
Keefe, 2013). Given such difficulties, it is imperative that large-scale awareness campaigns are 
undertaken to educate individuals throughout various referral pathways (e.g., campus health 
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clinics, primary care clinics). Education may include topics such as assessment and detection of 
subthreshold negative psychotic symptoms in adolescents and young adults, and the differential 
diagnosis between negative symptoms and depressive symptoms (Nelson et al., 2013). Class 3 
(negative-neurocognitive) was further characterized by extensive neurocognitive impairments 
that likely occurred over the course of several years (Kahn & Keefe, 2013). Some researchers 
have proposed that psychosis is primarily a cognitive disorder, and that early recognition and 
prevention programs are failing to address the key risk phenotype of cognitive decline or 
intellectual stagnation that occurs around puberty (Kahn & Keefe, 2013). Large population based 
studies must be conducted to determine the level and pattern of cognitive underperformance that 
is associated with later functional decline. Efficacious treatments may then be developed and 
implemented.  
Much of the current neurocognition and negative symptom intervention research has been 
conducted in older individuals with chronic psychosis and require adaptation for younger 
populations. To ameliorate neurocognitive deficits, a small number of studies have used 
cognitive remediation therapy (CRT) in CHR individuals, and found evidence in support of 
cognitive improvement (Hooker et al., 2014; Loewy et al., in press; Piskulic et al., 2015; 
Rauchensteiner et al., 2011). However, the tolerability and feasibility of CRT for adolescents is 
questionable given the high rates of dropout (i.e., 42% in Loewy et al., 2016) compared to 
similar CRT protocols in individuals with recent-onset schizophrenia. It is therefore imperative 
to develop rewarding and engaging forms of CRT for this young group to prevent attrition (i.e., 
incorporating interactive video game style play). Regarding negative symptoms, current 
treatments of negative symptoms in psychotic spectrum illnesses evidence statistically significant 
changes in symptoms; however, have not been found to be clinically meaningful (Fusar-Poli et 
  87 
al., 2015). Thus, it is clear that the field is in great need of efficacious and tolerable treatments 
for neurocognitive and negative symptoms in individuals at CHR. 
Individuals in class 2 (positive-depressive) exhibited a mix of subpsychotic 
symptomatology, depressive symptoms, and profound social dysfunction. It would be beneficial 
to conduct longitudinal studies lasting through age 30 to better assess the potential for symptom 
crossover and illness progression in this class. Treatments may be tailored to emerging diagnoses 
in line with the clinical staging model (McGorry et al., 2006). Given class 2’s (positive-
depressive) relative lower risk of transition to psychosis compared to class 3 (negative-
neurocognitive), it may be recommended to treat their wide range of symptoms and possible 
underlying mechanisms rather than specialize in psychosis prevention, as may be indicated for 
class 3 (negative-neurocognitive). 
Finally, given the low level of social functioning across a majority of individuals in the 
present study, treatments addressing such dysfunction rather than targeting determinants of such 
may be of interest. Such dysfunction is worthy of intervention in its own right, but also puts 
individuals at risk for various other forms of psychopathology (Cotter et al., 2014). Broadly, the 
present study highlights gaps in current knowledge concerning social dysfunction—in particular, 
causes, correlates, and course. Future research would also benefit from a focus in predictors of 
functionality and the incorporation of resiliency factors.  
Conclusions  
Overall, the present results support a subgroup approach to research, assessment, and 
treatment of help seeking individuals. Three classes emerged with adequate separation on a 
majority of indicator variables (SOPS symptoms, CDSS total score, neurocognitive scores), 
including a class that may be an early manifestation of the deficit subtype. Despite the well-
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established association between poor outcome and negative symptoms and neurocognitive 
deficits, such symptom clusters are rarely targeted in CHR individuals. Further, the present 
findings underline the profound social dysfunction across help seeking individuals and need for 
improved treatments. We join other researchers who have advocated for a transdiagnostic, 
heuristic approach to CHR individuals that has been emphasized in understanding the 
progression to psychosis (Heinssen and Insel, 2015; McGorry et al., 2007).  
 
  
APPENDIX A: SCHEDULE OF ASSESSMENTS 
 
  Year 1 Year 2 
Study Evaluations 
V
1 
V
2 
V
3 
V
4 
V
5 
V
6 
V
7 
V
8 
V
9 
V 
10 
V 
11 
V 
12 
V 
13 
V 
14 
V 
15 
V 
16 
Cumulative months 0 1 2 3 4 5 6 8 10 12 14 16 18 20 22 24 
Symptom Measures                                 
Structured Interview for Prodromal Syndromes 
(SIPS), Scale of Prodromal Symptoms (SOPS), and 
Criteria of Prodromal Syndromes (COPS) x x x x x x x x x x x x x x x x 
Alcohol/Drug Use Scale (AUS/DUS) x x x x x x x x x x x x x x x x 
Calgary Depression Scale for Schizophrenia (CDSS) x           x     x     x     x 
Young Mania Rating Scale (YMRS) x      x   x   x   x 
Personal Beliefs about Experiences Questionnaire 
(PBEQ)  x           x     x     x     x 
Social Cognitive Measures                                 
Eyes Task x           x     x     x     x 
Facial Emotion Identification Task (FEIT) x           x     x     x     x 
Facial Emotion Discrimination Task (FEDT) x           x     x     x     x 
Affective Prosody Task (AP) x           x     x     x     x 
Functioning Measures                                  
Social Functioning Scale (SFS) x           x     x     x     x 
Heinrich Quality of Life (Modified)-Role Functioning 
(QLS) x           x     x     x     x 
Premorbid Adjustment Scale (PAS) x                               
Neurocognitive Measures                                 
Neurocognitive Test Battery x           x     x     x     x 
Note. V = visit; x = administered; Cumulative months, 0 = baseline.  
(J. Addington, personal communication, May 20, 2015) 
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APPENDIX B: REASONS FOR DROPOUT 
 
 
 
 Assessment (years) 
 0 0.5 1 1.5 2 2.5 3 3.5 4 
Clinical High Risk (CHR) 
Completed 171 93 66 43 32 26 17 12 7 
Study ended 0 3 22 38 53 64 82 98 106 
No Show 0 56 62 66 58 53 44 33 30 
Converted 0 19 22 25 29 29 29 29 29 
Help seeking controls (HSC) 
Completed 100 61 52 43 32 23 16 6 1 
Study ended 0 0 6 13 23 32 49 64 76 
No Show 0 38 40 41 41 40 30 25 18 
Converted 0 1 2 3 4 5 5 5 5 
Combined Sample 
Completed 271 154 118 86 64 49 33 18 8 
Study ended 0 3 28 51 76 96 131 162 182 
No Show 0 94 102 107 99 93 74 58 48 
Converted 0 20 24 28 33 34 34 34 34 
(J. Addington, personal communication, March 23, 2016) 
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APPENDIX C: CLINICAL STAGING MODEL OF PRODROMAL PREVENTION 
 
 
(Figure from Fusar-Poli, Yung, et al., 2014)  
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APPENDIX D: DSM-IV DIAGNOSIS AT CONVERSION 
 
 
Conversion Diagnosis 
DSM-IV 
Code 
Class 1 
(Mild) 
Class 2 
(Positive-
Depressive) 
Class 3 
(Negative-
Neurocognitive) Total 
Schizophrenia 295.00 1 3 2 6 
Schizophreniform Disorder 295.40 3 2 5 10 
Schizoaffective Disorder 295.70 1 1 0 2 
Psychotic Disorder Not Otherwise 
Specified 298.90 1 6 4 11 
Bipolar I with psychotic features 296.04 1 2 1 4 
Bipolar II with psychotic features 296.89 0 1 0 1 
Total  7 15 12 34 
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Table 1. Measures of Neurocognition and Social Cognition and Associated Normative Data 
 Domain Test Variable 
employed 
(range) 
Healthy Controls 
M (SD) 
NC Verbal 
fluency 
Category Instances (CAT) (Benton, 
Hamsher, & Sivan, 1989) 
Mean correct  
across trials 
Not available 
NC Executive 
functioning 
Wisconsin Card Sorting Test, 64-
card computerized version 
(WCST) (Kongs et al., 2000) 
Perseverative 
errors  
6.92 (5.04) 
(Strauss, Sherman, 
& Spreen, 2006) 
Trail Making Test B (TMT) 
(Reitan & Wolfson, 1985) 
Time to 
completion 
(seconds) 
49.82 (12.52) 
(Tombaugh, 2004) 
NC Speed of 
processing 
Trail Making Test A (TMT) 
(Reitan & Wolfson, 1985) 
Time to 
completion 
(seconds)  
23.66 (7.79) 
(Tombaugh, 2004) 
NC Verbal 
explicit 
memory 
Rey Auditory Verbal Learning Test 
(RAVLT) (Rey, 1958) 
Total recall, 
trials 1-5 (0-
75) 
54.73 (7.43) 
(Strauss et al., 
2006) 
NC Attention Continuous Performance Test-
Identical Pairs (CPT-IP) (Cornblatt 
& Keilp, 1994) 
Mean response 
sensitivity (d’) 
3 digit  
3.56 (0.12) (Kahn 
et al., 2012) 
SC Theory of 
Mind 
Reading the Mind in the Eyes Task 
(Baron-Cohen et al., 2001) 
Total correct 
(0-36) 
26.2 (3.6) (Baron-
Cohen et al., 2001) 
SC 
 
Emotion 
Perception 
Face Emotion Identification Task 
(FEIT) (Kerr & Neale, 1993) 
Total correct 
(0-19) 
13.42 (2.18) 
(Pinkham & Penn, 
2006) 
Face Emotion Discrimination Task 
(FEDT) (Kerr & Neale, 1993) 
Total correct 
(0-30) 
26.47 (2.30) 
(Pinkham & Penn, 
2006) 
Affective Prosody Task (AP) 
(Edwards et al., 2001) 
Total correct 
(0-60) 
49.46 (6.27) 
(Edwards et al., 
2001) 
NC, Neurocognition; SC, Social Cognition 
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Table 2. Fit Indices and Class Sizes for the Latent Profile Analysis of SOPS Symptom Scores, CDSS Total 
Score, and Neurocognitive Scores 
 Number of classes 
 1 2 3 4 5 
Loglikelihood -14339.751 -14026.772 -13839.33 -13729.856 -13644.023 
No. of 
parameters 52 79 106 133 160 
AIC 28783.501 28211.544 27890.66 27725.713 27608.047 
BIC 28970.812 28496.111 28272.484 28204.795 28184.386 
ssa BIC 28805.935 28245.626 27936.39 27783.091 27677.074 
Entropy n/a 0.909 0.884 0.907 0.925 
Bootstrap LRT  p<.0001 p<.0001 p<.0001 p<.0001 
Class size 271 209/62 124/106/41 27/35/110/99 91/27/96/26/31  
SOPS: Scale of Prodromal Symptoms; AIC: Akaike’s Information Criteria (smaller number suggests a 
better model); BIC: Bayesian Information Criteria (smaller number suggests a better model); ssa BIC: 
sample size-adjusted Bayesian Information Criteria (smaller number suggests a better model); Entropy, an 
overall measure of how well a model predicts class membership, ranging from 0 (no predictive power) to 
1 (perfect prediction) (above .80 indicates adequate predictive power); LRT: parametric bootstrapped 
likelihood ratio test to compare n with n – 1 classes (significant LRT indicates the n-class solution is 
better than an (n – 1)-class solution; Class size, estimated class size based on most likely class 
membership.  
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Table 3. Latent Class Membership Based Upon Estimated Posterior Probabilities 
Class Based on 
estimated 
posterior 
probability n 
(%) 
Based on most 
likely class 
membership n 
(%) 
Class 1 
Mild 
Class 2 
Positive 
Class 3 
Negative 
1 125.11 (46.2) 124 (45.8) 0.956 0.036 0.008 
2 105.71 (39.0) 106 (39.1) 0.048 0.945 0.007 
3 40.18 (14.8) 41 (15.1) 0.034 0.027 0.939 
The first column indicates class membership based on the mean estimated posterior probability. The 
second column shows the classification of subjects in each class based on their highest posterior 
probability (most likely class membership). Columns Class 1-Class 3 indicate the average latent class 
probabilities for most likely latent class membership (row) by latent class (column). This means that 
individuals classified into class 1 had an average posterior probability for membership in class one of 
95.6%. Individuals classified in class 1 had average posterior probabilities of belonging to class 2 of 4.8% 
and class 3 of 3.4%. 
 
  
Table 4. Latent Profile Analysis of SOPS, CDSS, and Neurocognition: Estimated Parameters for the Three-Class Solution 
Indicator Class 1  
(n = 124) 
Class 2  
(n = 106) 
Class 3  
(n = 41) 
ANOVA 
p 
 
Pairwise 
Effect 
Size (r2) 
P1: Unusual Thought Content/Delusional 
Ideas 2.4 (0.18) 3.1 (0.15) 2.6 (0.40) 
.002 2>1 0.05 
P2: Suspiciousness/Persecutory Ideas 1.8 (0.17) 2.7 (0.15) 1.9 (0.37) p<.001 2>1,3 0.08 
P3: Grandiose Ideas 1.0 (0.13) 1.0 (0.13) 0.9 (0.23) .629  0.00 
P4: Perceptual Abnormalities/Hallucinations 1.7 (0.17) 2.6 (0.15) 2.2 (0.37) p<.001 2>1 0.07 
P5: Disorganized Communication 1.1 (0.14) 1.6 (0.13) 1.7 (0.25) .001 2,3>1 0.06 
N1: Social Anhedonia  0.9 (0.18) 1.8 (0.17) 2.8 (0.68) p<.001 3>1,2; 2>1 0.16 
N2: Avolition 0.8 (0.19) 2.3 (0.19) 2.8 (0.45) p<.001 3,2>1 0.35 
N3: Decreased Expression of Emotion 0.5 (0.16) 1.1 (0.16) 1.9 (0.46) p<.001 3>1,2; 2>1 0.16 
N4: Decreased Experience of Emotions/Self 0.7 (0.12) 1.8 (0.16) 1.5 (0.45) p<.001 2,3>1 0.15 
N5: Decreased Ideational Richness  0.4 (0.11) 0.8 (0.11) 2.2 (0.58) p<.001 3>1,2; 2>1 0.29 
N6: Occupational Functioning 1.2 (0.42) 2.9 (0.26) 3.8 (0.36) p<.001 3>1,2; 2>1 0.25 
D1: Odd Behavior or Appearance 0.5 (0.12) 0.6 (0.11) 2.0 (0.64) p<.001 3>1,2 0.20 
D2: Bizarre Thinking 0.7 (0.14) 0.8 (0.11) 1.2 (0.27) .081  0.02 
D3: Trouble with Focus and Attention 1.2 (0.21) 2.3 (0.14) 2.5 (0.24) p<.001 2,3>1 0.23 
D4: Impairment in Personal Hygiene 0.3 (0.13) 0.7 (0.14) 1.3 (0.47) p<.001 3>1,2; 2>1 0.09 
G1: Sleep Disturbance 0.9 (0.13) 2.5 (0.15) 1.7 (0.47) p<.001 2>1,3; 3>1 0.29 
G2: Dysphoric Mood 1.3 (0.20) 3.5 (0.15) 3.0 (0.51) p<.001 2>1,3; 3>1 0.44 
G3: Motor Disturbances 0.3 (0.06) 0.8 (0.10) 0.8 (0.40) p<.001 2,3>1 0.08 
G4: Impaired Tolerance to Normal Stress 0.8 (0.14) 2.6 (0.18) 2.4 (0.52) p<.001 2,3>1 0.30 
CDSS Total Score 2.0 (0.28) 5.8 (0.45) 3.8 (1.15) p<.001 2>1,3; 3>1 0.24 
CAT Total Score 47.2 (1.62) 49.9 (1.41) 32.5 (2.41) p<.001 1,2>3 0.22 
WCST Perseverative Errors 6.4 (0.36) 6.8 (0.43) 12.9 (2.68) p<.001 3>1,2 0.20 
TMT A 26.6 (1.22) 24.2 (0.82) 43.2 (4.91) p<.001 3>1,2 0.36 
TMT B 62.0 (5.51) 53.8 (1.86) 107.3 (9.90) p<.001 3>1,2 0.35 
CPT D’3 2.7 (0.09) 2.9 (0.09) 1.8 (0.27) p<.001 1,2>3 0.18 
RAVLT Total Score 53.52 (2.74) 55.46 (1.05) 43.10 (5.17) p<.001 1,2>3 0.21 
P, positive symptom; N, negative symptom; D, disorganized symptom; G, general symptom; CDSS, Calgary Depression Scale for Schizophrenia; 
CAT: category instances; WCST, Wisconsin Card Sorting Test; TMT, Trail Making Test; CPT, Continuous Performance Test; RAVLT, Rey 
Auditory Verbal Learning Test. Mean parameter estimates and associated standard errors for each latent class are provided; mean parameter 
estimate (standard error). Pairwise comparisons are significant at the p < .05 level. 
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Table 5. Associations Between Latent Classes and Demographic Characteristics  
 Class 1 (n = 
124) 
Class 2 
(n = 106) 
Class 3  
(n = 41) 
Test 
Age, mean (SD) 19.48 (4.26) 20.71 (4.03) 17.26 (4.09) F2,268 = 10.36, p < 0.001; 
pairwise 2>3 
Sex, n (% within class)     
Male 69 (55.6) 59 (55.7) 26 (63.4) χ22 = .86, p = 0.65 
Female 55 (44.4) 47 (44.3) 15 (36.6) 
Race/ethnicity, n (% within class)     
White 93 (75.0) 82 (77.4) 29 (70.7) χ28 = 8.53, p = 0.38 
Black  13 (10.5) 9 (8.5) 7 (17.1) 
Asian 9 (7.3)  8 (7.5) 0 (0.0) 
Native Hawaiian/Pacific Islander 0 (0.0) 1 (0.9) 0 (0.0) 
Mixed 9 (7.3) 6 (5.7) 5 (12.2) 
Hispanic, n (% within class)     
Yes 14 (11.3) 11 (10.4) 5 (12.2) χ22 = .11, p = 0.95 
No 110 (88.7) 95 (89.6) 36 (87.8) 
Parental education, n (%)     
Did not complete high school 13 (10.6) 6 (5.7)  9 (22.0) χ216 = 19.78, p = 0.23 
Unknown 16 (13.0) 12 (11.4) 10 (24.4) 
GED or equivalent 18 (14.6) 9 (8.6) 3 (7.3) 
Some college, did not graduate 10 (8.1) 12 (11.4) 1 (2.4) 
Community college or technical school degree 33 (26.8) 31 (29.5) 9 (22.0) 
College graduate 3 (2.4) 4 (3.8) 1 (2.4) 
College graduate and some master’s level courses 14 (11.4) 16 (15.2) 5 (12.2) 
Master’s degree completed 3 (2.4) 4 (3.8) 1 (2.4) 
Advanced degree courses, did not graduate 13 (10.6) 11 (10.5) 2 (4.9) 
If did not complete HS/GED, # years edu: M (SD) 8.78 (2.91) 10.50 (.58) 9.11 (2.37) F2,15 =0.88, p < 0.43 
Clinic, n (% within class)     
University of North Carolina at Chapel Hill 40 (32.3)a 42 (39.6)a 4 (9.8)b χ24 = 16.90, p = 0.002 
University of Toronto 52 (41.9)a 44 (41.5)a 18 (43.9)a 
Yale University 32 (25.8)a 20 (18.9)a 19 (46.3)b 
Subscript letters note a class whose column proportions do not differ significantly from each other using z-square cell comparison tests with 
Bonferroni correction. Differing subscript letters note significant differences between classes (p < .05)
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Table 6. Associations Between Classes and Covariates  
 Class 1  
(n = 124) 
Class 2 
(n = 106) 
Class 3  
(n = 41) 
 
Test 
 
Pairwise 
Symptomatology      
Risk group, n (% within class)      
Clinical high risk (CHR, n=171) 66 (53.2)a 79 (74.5)b 26 (63.4)a, b χ22 = 11.14, p = 0.004 
 
Help seeking control (HSC, n=100) 58 (46.8)a 27 (25.5)b 15 (36.6)a, b  
YMRS total score, mean (SD) 1.97 (2.80) 3.27 (3.99) 3.88 (4.14) F2,263 = 6.17, p = 0.002 2,3>1 
Internalized stigma, mean (SD)      
PBEQ total score 27.54 (4.83) 31.63 (4.32) 30.54 (5.59) F2,237 = 19.13, p < 0.001 2,3>1 
PBEQ “control over experiences” 
subscale 
6.33 (1.90) 7.78 (1.61) 7.15 (2.10) F2,237 = 15.46, p < 0.001 2,3>1 
Alcohol use/drug use, mean (SD)      
Alcohol 1.58 (0.51) 1.61 (0.58) 1.41 (0.67) F2,266 = 1.81, p = 0.166  
Marijuana or THC 1.35 (0.60) 1.42 (0.68) 1.29 (0.75) F2,266 = .64, p = 0.529  
Cocaine 1.07 (0.34) 1.09 (0.37) 1.00 (0.00) F2,266 = 1.05, p = 0.351  
Opiates  1.04 (0.30) 1.05 (0.35) 1.00 (0.00) F2,266 = 0.39, p = 0.675  
Amphetamines  1.03 (0.18) 1.01 (0.10) 1.00 (0.00) F2,266 = 1.28, p = 0.281  
MDMA/ecstasy 1.07 (0.26) 1.02 (0.14) 1.00 (0.00) F2,266 = 3.19, p = 0.043  
GHB 1.01 (0.09) 1.00 (0.00) 1.00 (0.00) F2,265 = 0.59, p = 0.556  
Huffing glue/other volatiles 1.01 (0.09) 1.00 (0.00) 1.00 (0.00) F2,266 = 0.59, p = 0.554  
Hallucinogens 1.07 (0.29) 1.11 (0.35) 1.00 (0.00) F2,266 = 2.26, p = 0.106  
Other 1.01 (0.09) 1.09 (0.31) 1.00 (0.00) F2,266 = 4.83, p = 0.009 2>1 
Functioning      
Pre-morbid Adjustment (PAS), mean 
(SD) 
     
Child Social Maladjustment 0.16 (0.20) 0.20 (0.20) 0.30 (0.23) F2,250 = 7.44, p = 0.001 3>1,2 
Child Acad. Maladjustment 0.17 (0.18) 0.18 (0.19) 0.29 (0.22) F2,250 = 6.76, p = 0.001 3>1,2 
Early Adol. Social Maladjustment 0.21 (0.20) 0.25 (0.19) 0.36 (0.20) F2,247 = 8.78, p < 0.001 3>1,2 
Early Adol. Acad. Maladjustment 0.25 (0.21) 0.28 (0.24) 0.40 (0.27) F2,247 = 7.44, p = 0.001 3>1,2 
Late Adol. Social Maladjustment 0.19 (0.19) 0.30 (0.20) 0.48 (0.29) F2,187 = 17.58, p < 0.001 3>1,2; 2>1 
Late Adol. Acad. Maladjustment 0.23 (0.21) 0.35 (0.25) 0.48 (0.30) F2,180 = 10.80, p < 0.001 2,3>1 
Early/Late Adol. Social Avg. 0.19 (0.18) 0.27 (0.18) 0.41 (0.24) F2,187 = 12.10, p < 0.001 3>1,2; 2>1 
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Heinrichs-Carpenter QLS       
Occupational functioning 5.13 (1.49) 4.82 (1.81) 3.68 (2.45) F2,243 = 9.35, p < 0.001 1,2>3 
Accomplishment 4.32 (1.45) 3.54 (1.77) 2.42 (1.64) F2,243 = 20.74, p < 0.001 1,2>3; 1>2 
Underemployment 4.74 (1.47) 3.79 (1.77) 2.79 (1.89) F2,243 = 6.37, p = 0.002 1,2>3; 1>2 
Role satisfaction 4.79 (1.65) 3.93 (1.78) 3.82 (1.79) F2,189 = 21.96, p < 0.001 1>2 
QLS total score (1-3) 14.19 (3.91) 12.15 (4.83) 8.89 (5.62) F2,243 = 19.83, p < 0.001 1,2>3; 1>2 
Social cognition, mean (SD)      
Eyes Task total score 26.22 (4.53) 25.77 (4.15) 19.92 (4.55) F2,228 = 29.57, p < 0.001 1,2>3 
FEIT total score 13.23 (2.28) 12.84 (2.12) 10.97 (2.77) F2,226 = 12.86, p < 0.001 1,2>3 
FEDT total score 25.67 (1.86) 25.80 (1.96) 24.89 (2.08) F2,227 = 2.97, p = 0.053  
AP total score 45.90 (5.24) 45.71 (5.27) 37.26 (9.45) F2,221 = 29.20, p < 0.001 1,2>3 
Neurocognition, mean (SD)      
IQ Score 113.58 (17.22) 115.27 (15.42) 87.10 (12.44) F2,186 = 27.30, p < 0.001 1,2>3 
  YMRS, Young Mania Rating Scale; PBEQ, Personal Beliefs about Experiences Questionnaire; QLS, Quality of Life Scale; FEIT, Face Emotion 
Identification Task; FEDT, Face Emotion Discrimination Task; AP, Affective Prosody Task. 
Subscript letters note a class whose column proportions do not differ significantly from each other using z-square cell comparison tests with 
Bonferroni correction, while differing subscript letters note significant differences between classes (p < .05) 
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Table 7. Descriptive Statistics and Mean Estimates of SFS by Class, Across Time Points 
 
 Mean 
Estimate SE  Mean  SD 
 
n 
Class 1 – Baseline  123.37 2.30 123.43 29.07 113 
Class 1 – 6 month 130.57 2.75 132.19 16.01 67 
Class 1 – 12 month 127.08 2.93 127.36 17.08 56 
Class 1 – 18 month  125.41 3.37 129.26 21.00 38 
Class 1 – 24 month 127.53 3.79 133.25 20.52 28 
Class 2 – Baseline  112.15 2.53 112.38 25.31 93 
Class 2 – 6 month 117.83 3.08 117.36 28.61 53 
Class 2 – 12 month 121.84 3.37 120.24 22.87 41 
Class 2 – 18 month 122.01 3.61 118.82 20.34 34 
Class 2 – 24 month 125.05 4.25 121.18 23.37 22 
Class 3 – Baseline 106.05 3.88 106.05 21.07 40 
Class 3 – 6 month 112.94 4.64 115.88 23.05 24 
Class 3 – 12 month 116.68 5.23 118.41 26.48 17 
Class 3 – 18 month 113.39 5.94 115.50 25.99 12 
Class 3 – 24 month 102.65 6.62 104.11 19.68 9 
SE, Standard Error; SD, Standard Deviation 
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Table 8. Generalized Linear Mixed Model Between Classes for SFS Over Time 
 
Mean 
Estimate 
Difference 
Between 
Groups  
Standard 
Error df t  
Uncorrected 
p 
Hochberg 
p 
Class 1 vs. Class 2       
Baseline: Class 1 vs. Class 2 11.22 3.42 382 3.28 0.001 0.015 
6 Month: Class 1 vs. Class 2 12.74 4.13 382 3.09 0.002 0.024 
12 Month: Class 1 vs. Class 2 5.24 4.47 382 1.17 0.242 0.664 
18 Month: Class 1 vs. Class 2 3.40 4.94 382 0.69 0.491 0.664 
24 Month: Class 1 vs. Class 2 2.47 5.69 382 0.43 0.664 0.664 
Class 1 vs. Class 3       
Baseline: Class 1 vs. Class 3 17.32 4.51 382 3.84 < 0.000 0.002 
6 Month: Class 1 vs. Class 3 17.63 5.39 382 3.27 0.001 0.015 
12 Month: Class 1 vs. Class 3 10.40 6.00 382 1.73 0.084 0.664 
18 Month: Class 1 vs. Class 3 12.03 6.83 382 1.76 0.079 0.664 
24 Month: Class 1 vs. Class 3 24.88 7.63 382 3.26 0.001 0.015 
Class 2 vs. Class 3       
Baseline: Class 2 vs. Class 3 6.10 4.63 382 1.32 0.188 0.664 
6 Month: Class 2 vs. Class 3 4.88 5.57 382 0.88 0.381 0.664 
12 Month: Class 2 vs. Class 3 5.17 6.23 382 0.83 0.407 0.664 
18 Month: Class 2 vs. Class 3 8.62 6.95 382 1.24 0.216 0.664 
24 Month: Class 2 vs. Class 3 22.40 7.87 382 2.85 0.005 0.047 
SFS, Social Functioning Scale; df, degrees of freedom; Mean estimate difference between groups is the 
absolute value. 
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Table 9. Generalized Linear Mixed Model Within Group Analysis for SFS Over Time   
 
Change 
in Mean 
Estimate 
Standard 
Error df t  
Uncorrected 
p 
Hochberg 
p 
Class 1: Baseline vs. 6 Month 7.21 2.64 382 -2.73 0.007 0.099 
Class 1: Baseline vs. 12 Month 3.71 2.81 382 -1.32 0.186 0.965 
Class 1: Baseline vs. 18 Month 2.05 3.26 382 -0.63 0.531 0.965 
Class 1: Baseline vs. 24 Month 4.16 3.69 382 -1.13 0.261 0.965 
Class 1: 12 Month vs. 18 Month -1.67 3.49 382 0.48 0.634 0.965 
Class 1: 12 Month vs. 24 Month 0.45 3.91 382 -0.11 0.909 0.965 
Class 2: Baseline vs. 6 Month 5.68 2.95 382 -1.93 0.055 0.654 
Class 2: Baseline vs. 12 Month 9.69 3.26 382 -2.97 0.003 0.053 
Class 2: Baseline vs. 18 Month 9.86 3.50 382 -2.81 0.005 0.082 
Class 2: Baseline vs. 24 Month 12.91 4.15 382 -3.11 0.002 0.036 
 Class 2: 12 Month vs. 18 Month 0.17 3.83 382 -0.04 0.965 0.965 
Class 2: 12 Month vs. 24 Month 3.21 4.46 382 -0.72 0.471 0.965 
Class 3: Baseline vs. 6 Month 6.89 4.39 382 -1.57 0.117 0.965 
Class 3: Baseline vs. 12 Month 10.63 5.01 382 -2.12 0.035 0.484 
Class 3: Baseline vs. 18 Month 7.34 5.74 382 -1.28 0.202 0.965 
Class 3: Baseline vs. 24 Month -3.40 6.45 382 0.53 0.598 0.965 
Class 3: 12 Month vs. 18 Month -3.29 6.23 382 0.53 0.598 0.965 
Class 3: 12 Month vs. 24 Month -14.02 6.89 382 2.03 0.043 0.554 
SFS, Social Functioning Scale; df, degrees of freedom; Change in Mean Estimate is second time point 
subtracted from first time point. 
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Table 10. Class Membership: Results of the Multinomial Regression Analysis of Covariates 
 B 
(S.E.) 
OR (95% CI) 
Wald χ2 p 
Class 2     
Intercept 3.08    
Child Academic Maladjustment -1.89 0.15 (0.02-1.10) 1.01 .062 
Early Adolescent Social Maladjustment 1.46 4.31 (0.75-24.65) 2.70 .101 
QLS Total Score -0.11 0.90 (0.83-0.96) 9.03 .003 
Eyes Task Total Score -0.01 0.99 (0.92-1.08) 0.03 .859 
FEIT Total Score -.14 0.87 (0.75-1.01) 3.50 .061 
AP Total Score .00 1.00 (0.94-1.07) 0.01 .930 
     
Class 3     
Intercept 13.67    
Child Academic Maladjustment 1.76 5.82 (0.35-97.72) 1.50 .221 
Early Adolescent Social Maladjustment 3.17 23.81 (1.63-347.86) 5.37 .021 
QLS Total Score -0.28 0.76 (0.68-0.86) 20.70 < .001 
Eyes Task Total Score -0.24 0.79 (0.69-0.90) 11.56 .001 
FEIT Total Score -0.23 0.80 (0.63-1.02) 3.32 .069 
AP Total Score -0.11 0.89 (0.82-0.98) 5.52 .019 
QLS, Heinrichs-Carpenter Quality of Life Scale; FEIT, Face Emotion Identification Task; AP, 
Affective Prosody Task; OR, odds ratio; CI, confidence interval; S.E., standard error. 
Class 1 (mild) was selected as the reference group.  
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Table 11. Modeled Probability (%) of Being Assigned to a Class Based on Covariates 
Clinical Characteristic 
Class 1 
(Mild) 
Class 2 
(Positive-
Depressive) 
Class 3 
(Negative-
Neurocognitive) 
Low Childhood Academic Maladjustment 44.29 52.94 2.78 
Average Childhood Academic Maladjustment 51.75 43.77 4.48 
High Childhood Academic Maladjustment 58.20 34.84 6.96 
Low Early Adolescent Social Maladjustment 59.76 37.53 2.71 
Average Early Adolescent Social Maladjustment 51.75 43.77 4.48 
High Early Adolescent Social Maladjustment 43.40 49.43 7.17 
Low Role Functioning 35.48 52.27 12.25 
Average Role Functioning 51.75 43.77 4.48 
High Role Functioning 66.34 32.22 1.44 
Low Theory of Mind 46.30 40.62 13.08 
Average Theory of Mind 51.75 43.77 4.48 
High Theory of Mind 54.28 44.27 1.44 
Low Face Emotion Recognition 42.54 51.07 6.39 
Average Face Emotion Recognition 51.75 43.77 4.48 
High Face Emotion Recognition 60.76 36.21 3.03 
Low Affective Prosody Ability 49.59 41.15 9.26 
Average Affective Prosody Ability 51.75 43.77 4.48 
High Affective Prosody Ability 52.57 45.32 2.11 
 
  
 
Figure 1. Scree Plots. Y-axis represents information criteria value for each plot (e.g., AIC value). X-axis represents k classes. AIC, Akaike’s 
Information Criteria; BIC, Bayesian Information Criteria; ssa BIC, sample size adjusted Bayesian Information Criteria.
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Figure 2. Kaplan-Meier Survival Plot of transition to psychosis within 5 years of referral. Cumulative survival indicates the % of the class that did 
not transition to psychosis across time. 
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Figure 3. Latent profile plot of Scale of Prodromal Symptoms (SOPS) items and Calgary Depression 
Scale for Schizophrenia (CDSS) total score. Estimated sample means of each indicator for the three-class 
model. P1, Unusual Thought Content/Delusional Ideas; P2, Suspiciousness/Persecutory Ideas; P3, 
Grandiose Ideas; P4, Perceptual Abnormalities/Hallucinations; P5, Disorganized Communication; N1, 
Social Anhedonia; N2, Avolition; N3, Decreased Expression of Emotion; N4, Decreased Experience of 
Emotions and Self; N5, Decreased Ideational Richness; N6, Occupational Functioning; D1, Odd Behavior 
or Appearance; D2, Bizarre Thinking; D3, Trouble with Focus and Attention; D4, Impairment in Personal 
Hygiene; G1, Sleep Disturbance; G2, Dysphoric Mood; G3, Motor Disturbances; G4, Impaired Tolerance 
to Normal Stress; CDSS, Calgary Depression Scale for Schizophrenia total score. 
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Figure 4. Latent profile plot of neurocognitive scores. CAT, Category Instances; RAVLT, Rey Auditory 
Verbal Learning Test; WCST PE, Wisconsin Cart Sorting Test Perseverative Errors; Trails A, Trail 
Making Test A; Trails B, Trail Making Test B; D’3, Continuous Performance Test-Identical Pairs (CPT-
IP) D’3. 
 
  
 
 
Figure 5. Mean Estimates of Social Functioning Scale (SFS) Over Time by Class.  
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